PT91096B - Composicao de enxerto de tecido - Google Patents
Composicao de enxerto de tecido Download PDFInfo
- Publication number
- PT91096B PT91096B PT91096A PT9109689A PT91096B PT 91096 B PT91096 B PT 91096B PT 91096 A PT91096 A PT 91096A PT 9109689 A PT9109689 A PT 9109689A PT 91096 B PT91096 B PT 91096B
- Authority
- PT
- Portugal
- Prior art keywords
- graft
- tissue
- segment
- cylinder
- tissue graft
- Prior art date
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02D—FOUNDATIONS; EXCAVATIONS; EMBANKMENTS; UNDERGROUND OR UNDERWATER STRUCTURES
- E02D5/00—Bulkheads, piles, or other structural elements specially adapted to foundation engineering
- E02D5/02—Sheet piles or sheet pile bulkheads
- E02D5/03—Prefabricated parts, e.g. composite sheet piles
- E02D5/04—Prefabricated parts, e.g. composite sheet piles made of steel
- E02D5/08—Locking forms; Edge joints; Pile crossings; Branch pieces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
- Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24008—Structurally defined web or sheet [e.g., overall dimension, etc.] including fastener for attaching to external surface
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Structural Engineering (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Paleontology (AREA)
- Pulmonology (AREA)
- Composite Materials (AREA)
- Gastroenterology & Hepatology (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Mining & Mineral Resources (AREA)
- Heart & Thoracic Surgery (AREA)
- Civil Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Prostheses (AREA)
Description
PURDUE RESEARCH FOUNDATION
MÉTODO PARA A PREPARAÇÃO DE UMA COMPOSIÇÃO DE ENXERTO DE TECIDO
MEMÓRIA DESCRITIVA
Resumo
Este invento relaciona-se com um método para a preparação de uma composição de enxerto de tecido a partir de um segmento do intestino delgado. A referida composição de enxerto de tecido compreende a túnica submucosa de um segmento do intestino delgado de um vertebrado de sangue quente em que a túnica submucosa é separada da túnica muscularis e que tem pelo menos a porção luminal da túnica mucosa. A composição de enxerto de tecido revelou possuir excelentes características mecânicas, assim como características de não-alergenicidade e de não-trombogenicidade em aplicações como autoenxertos vasculares, aloenxertos vasculares, e heteroenxertos vasculares.
FUNDAMENTOS DO INVENTO
Os materiais de enxerto de tecido atingiram hoje em dia um considerável significado clínico e económico. Avalia-se que em 19Só foram gastos $130 milhões apenas em enxertos vasculares, não incluindo os enxertos para bypass das artérias coronárias. Contudo as taxas de êxito para os processos de enxerto vascular são baixas em comparação com as da maior parte das outras técnicas cirúrgicas. Por exemplo, uma patencia cumulativa de 5 50X ê considerada excelente para enxertos vasculares de diâmetro. Essas taxas de êxito baixas resultam, em grande anos de pequena parte, materiais de uma ou mais deficiências :ísicas ou funcionais nos de enxerto correntemente utilizados na clínica.
A identificação de materiais apropriados para enxertos de tecido é particularmente difícil porque esses materiais devem possuir uma série de propriedades díspares.Por exemplo, os materiais de enxerto vascular devem não só apresentar estabilidade mecênica em situações de esforço contínuo, mas devem também ter uma. porosidade adequada para capi1 arização, resistência à pressão semelhante á do tecido hospedeira, e potenciais Zeta erem não trombogénicos). Além prefeZiltamerite negativos (de modo a disso devem ser não-a 1 ergénicos, não ca.rcinoqénicos, e de rência de fabrico não dispendioso.
Poucos, ou nenhuns, materiais de enxerto de tecido possuem todas as propriedades desejáveis. As referências bibliográficas da investigação e desenvolvimento no campo dos enxertos <ascu 1 ares ref 1 ec tem um esforço constante significativo para u1trapassar de f i.l. i. ênc ias ι_omuπ s dus mter i a i en xerto rorrentemente conhecidos owJ vKieiNM.
como
Foram utilizados materiais tanto sintéticos autogéneos para enxertos vasculares. Entre os sintéticos, o politetrafluoroetileno expandido (PTFE) é um material para enxerto vascular habitual mente utilizado, particularmente para cirurgias de bypass para vasos pequenos. Contudo, os enxertos de PTFE expandido são susceptíveis a hiperplasia neointima e a trombose tardia do enxerto (por exemplo, taxas de patencia de 6 anos de? aproximadamen te 5Θ7. para os bypasses f emoropopl i teus) . Os enxertos de PTFE são referidos como apresentando taxas de êxito ainda mais baixas quando utilizados na circulação venosa.
Um outro material sintético - Dacron R - é frequentemente utilizado para processos de enxertos vasculares de grande diâmetro (por exemplo, enxertos na aorta infrarenal>. Knitted Dacron contudo, tem uma porosidade reiativamente elevada e deve ser pré-coagu1ado antes da implantação a fim de evitar uma hemorragia intensa. Este processo de pré-coagu1 ação nem sempre é R prático ou coroado de êxito. Woven Dacron , embora menos poroso, apresenta uma resistência à pressão de apenas 207, da encontrada na aorta normal. F.inalmente os enxertos de Dacron^ actuam pobremente em artérias ou veias de pequeno diâmetro onde o fluxo sanguíneo é relativamente lento.
Um dos problemas mais significativos associados à utilização de produtos sintéticos como materiais de enxerto de tecido é o facto dos materiais sintéticos apresentarem uma baixa resistência à infecção. As taxas ção do enxerto sintético estão a de infecção a seguir à imolantaa uma mo r dade de 667». Os materiais sintéticos têm tendencia para albergar m i c ro o r g an i smos η os seus inter s t i c i os e , q uan d o c: on t a m i nad os, s ã d extremamente refractários á terapêutica antibacteriana. A explantação dos enxertos sintéticos infectados é virtualmente inevitábad original
Mais recentemente os ção de pele sintética s de utilizando células humanas viv 4.604.346, 4.546.5O0, 4.539.716 investigadores referiram preparaequivalentes de vasos sanguíneos as. Ver Patentes dos E.U.A. Nos. , 4.485.097, e 4.485.096.
Entre os materiais a.utoqéneos, a veia safena, a veiei umbilical humana, o intestino delgado invertido, e a artéria radial foram todos usados, mas cada um destes materiais apresentou também deficiências significativas. A veia safena pode ter um tamanho inapropriado para certos processos ou pode não se encontrar disponível devido a lesão por doença. Além disso, a veia safena pode apresentar varicosidades inaceitáveis e padece de aterogenese acelerada após arteriolização. Tanto os enxertos umbilicais como os enxertos de intestino delgada invertido são atingidos rápidamente por trombose e por formação posterior de aneurisma. Finalmente, a artéria radial apresenta utilidade limitada devido ao facto de ser de difícil colheita e de se poder deteriorar após a implantação do enxerto.
Constitui assim um objectivo deste invento proporcionar um material para enxerto de tecido gue não apresente muitas das deficiências associadas a muitos materiais de enxerto actualmente utilizados clínicamente.
Um outro objectivo deste invento consiste em proporcionar um método para preparar um novo material de enxerto de tecido a partir de um corte de intestino delgado.
Ainda um outro objectivo deste invento é o de proporcionar um método para utilização de um novo imaterial para enxerto de tecido com múltiplas finalidades em aplicações em autoenxertos, al o-enxertos e heteroenxertos.
BAD ORIGINal
Ainda ura outro objectivo deste invento é o de proporcionar ura método para utilização de uma. nova composição ae enxerta de tecido para substituição de vasos sanguíneos.
DESCRIÇgQ BREVE DO DESENHO
A Fig. 1 representa um corte transversal do intestino delgado.
DESCRIçao DETALHADA DQ INVENTO
Este invento é dirigido a uma composição de enxerta de tecido compreendendo principalmente a túnica submucosa de um segmento do intestino delgado de um vertebrado de sangue quente. A túnica submucosa é separada da túnica muscularis e pelo menos a porção luminal da túnica mucosa do corte do intestino delgado. Forque a presente composição de enxerto de tecido revelou possuir excelentes características funcionais em aplicações como au.toenxertos; vasculares e como aloenxertos vasculares, prevê—se que as composiçoes de enxerto de tecido deste invento vão encontrar ampla utilização mesmo como heteroenxertos em aplicações de enxertos tanto vasculares como noutros tecidos. Os requerentes descobriram que a. presente composição de enxerto de tecido apresenta múltiplas características físicas e biológicas que a tornam particu1armente adaptada para aplicações em enxertos de tec i d os .
Numa apresentação preferida deste invento, o material do enxerto de tecido compreende tecido da submucosa e tecida da mucosa basilar separados a partir de um corte de intestino delgado, com maior preferência do jejuno, uma porção do intestino delgado que se estende entre o duodeno e o íleo. 0 intestino delgado, antes da sua manipulação (separação de laminas) para
BAD ORIGINAL mucosa, particularmente a. lamina muscularis da mucosa Ε e o stratum compactum F. Aquelas camadas colectivamente são aqui a seguir referidas como a Submucosa dei Intestino Delgado (SIS).
Um autoenxerto de SIS de acordo com este invento pode ser preparado, por exemplo, fazendo primeiro a ressecçSo de um segmento do jejuno proximal autogéneo a seguir a uma incisão de laparotomia na linha média. 0 segmento de jejuna de que se fez a ressecçSo é então envolvido em esponjas cirúrgicas que foram embebidas em solução salina fisiológico (liquido fisiológico). Depois da anastomose intestinal ficar completa, o segmento intestinal de que se fez a ressecçSo é preparado de acordo com o método deste invento aqui a seguir descrito para utilização como material para enxerto de tecido. De um modo semelhante, os aloenxertos são preparados a partir de tecido intestinal removido de dadores de orgão/tecido da mesma espécie. Os heteroenxertos podem ser preparados, por exemplo, a partir de tecido intestinal felino, porcino ou bovino recuperado de animais sacrificados em operaçSes realizadas em matadouros. Até agora, foram encontradas diferenças morfológicas mínimas nos tecidos intestinais das diferentes espécies. Na verdade, verificou-se que o aspecto histológico do tecido de enxerto humano de acordo com este invento era quase idêntico ao do cão.A única diferença morfológica reconhecível era constituída por um stratum compactum ligeiramente menos denso no tecido humano.
D material de enxerto de tecido deste invento é preparado raspando o tecido intestinal a fim de remover as camadas exteriores incluindo tanto a túnica serosa como a túnica muscularis (camadas B e C na Fig. 1) e as camadas interiores incluindo pelo menos a porção lum.inal (camada G) da túnica mucosa (camadas E a G na Fig 1). Em condiçSes de raspaqem suave a túnica mucosa é deslaminada entre o stratum compactum (camada F) e a lamina basal bad da camada G. Mais particularmente, a seguir á remoção de quisquer tecidos mesentéricos do segmento intestinal utilizando, por exemplo, fórceps Adson-Brown e tesouras Metzenbaum, a tu.nica serosa e a túnica muscularis Cas camadas de tecido exteriores) são separadas do segmento intestinal por raspagem usando um movimento de esfregar longitudinal com um cabo de bisturi e gaze humedecida. A seguir à eversão do segmento intestinal, a porção lurninal da túnica mucosa ê separada do tecido subjacente usando o mesmo movimento de esfregar.Tem que se ter cuidada para evitar a perfuração da submucosa. São também removidos quaisquer apêndices de tecido das camadas separadas que permaneçam na superfície do enxerto. Facultativamente, o segmento intestinal pode ser primeiramente evertido, sendo em seguida liberto das camadas luminais, e sendo em seguida reinserido na sua orientação primitiva para remoção da túnica serosa e da túnica muscularis. 0 material de enxerto é constituído por um tubo de tecido translúcido, esbranquiçado, com aproximadamente 0,1 mm de espessura, consistindo tipicamente na túnica submucosa juntamente com a lamina muscularis da mucosa e o stratum compactum. Para a preparação do enxerto vascular, o enxerto preparado é evertido para a sua orientação primitiva de modo a que o stratum compactum sirva de superfície lurninal do enxerto.
material de enxerto preparado é tipicamente lavado com solução salina e colocado numa solução de sulfato de neomicina a 107. durante aproximadamente '20 minutos, e após esse período de tempo o material de enxerto está pronto para ser utilizado. Os enxertos são aplicados usando processos cirúrgicos de rotina habitualmente utilizados para aplicaçSes de enxertos de tecido. Para utilização em aplicaçSes de enxertos de tecido não vasculares, o material de enxerto tubular pode ser cortado longitudinalmente e enrolado para formar um remendo” de tecido. Na verdade, o processo total de separação de tecidos anteriormente descrito r 3
BAD ORIGINAL j pode ser realizado em remendos de tecido intestinal preparados cortando o segmento intestinal longitudinalmente e desenrolando—o para formar um remendo de pré-enxerto. Os remendos preparados de enxertos de tecido podem ser utilizados, por exemplo, como um material para enxerta da pele ou para a reparação de outros defeitos de tecidos do corpo adaptando—os para aplicação cirúrgica de um remendo de enxerto de tecido tendo caracteristicas físicas e funcionais da presente composição de enxerto.
Para utilização em enxertos vasculares, o enxerto deve ter um diâmetro mais ou menos igual ao diâmetro do vaso sanguíneo recipiente. Isto é realizado manipulando o enxerto de tecida de modo a. definir um cilindro tendo um diâmetro aproximadamente igual ao do vaso sanguíneo recipiente e suturando ou fechando bem de qualquer outro modo o enxerto de tecido longitudinalmente a. fim de formar o referido enxerto vascular. Assim, por exemplo, um enxerto vascular pode ser preparado seleccionando uma haste de vidro estéril tendo um diâmetro exterior igual ao do vaso sanguíneo recipiente e introduzindo a haste de vidro no lume do enxerta . 0 tecido redundante é então reunido e o diâmetro do lume desejado é conseguido suturando ao longo do comprimento do enxerto (por exemplo, usando duas linhas contínuas de sutura ou uma única linha, de sutura interrompida) ou usando outras técnicas de fechar bem tecidos reconhecidas nesta técnica.
Consistente com os objectivos deste invento, a composição SIS possui, propriedades mecânicas altamente desejáveis para matérias de enxerto de tecido, incluindo índice de porosidade baixo, elevada maleabilidade, e um ponto de pressão de rebentamento elevado. Quanto á porosidade, qualquer especialista nesta técnica terá em consideração que o material do enxerto de tecido deverá, ter uma porosidade suficientemente baixa de modo a evitar hemorragia intraoperatória embora tendo uma porosidade
BAD ORIGINAL suficientemente elevada para permitir -a extensão de u.m vasa vasorum recentemente desenvolvido através do material de enxerto a fim de alimentar a. neointima e a superfície luminal. A porosidade de um material de enxerto é medida tipicamente em termos de
-1 ml de áqua passados por cm min com uuma pressão de topo de 120 mm Hg. □ índice de porosidade do material de enxerta SIS é 10, muito mais baixo do que o de outros materiais de enxerto correntemente conhecidos nesta técnica. (Woven Dacrori^, por exemplo, tem um índice de porosidade de 5Õ). Contudo apesar deste baixo índice de porosidade, o SIS é ainda suficientemente poroso para permitir a ocorrência de neocapilarização no interior do enxerto de SIS. Nas aplicações de enxerto vascular as composições de SIS permitem a formação de capilares cheios de sangue no interior do enxerto estendendo-se até á superfície luminal quatro dias logo após a cirurgia.
Mo que se refere à resistência à pressão do enxerto, foi descrita nesta técnica a existência de uma relação directa entre a resistência à pressão e a patencia. Idealmente um material de enxerto deve possuir pelo menos uma resistência à pressão semelhante à do tecido qu.e ele substitui. A resistência à pressão longitudinal do material de enxerto SIS foi medida por meio da utilização de um teste tensil simples. Formou-se o comprimento do calibre inicial com duas marcas de tinta com 5,õ cm de distância. 0 alongamento e a força aplicada foram medidos quando as amostras foram carregadas a uma taxa de tensão de 32 cm/cm/min., proporcionando os resultados que se seguem:
'í bad original
Resistência à pressão do enxerto de SIS: 0,045 cm/N por cm
Resistência à pressão da aorta de cão normal: Θ,017 cm/N por cm de comprimento
Assim, os materiais de enxerto SIS apresentam na realidade uma resistência à pressão maior do que a da aorta normal. Isto constitui um progresso significativo em relação às técnicas anterioras no campo dos enxertos vasculares. Todos os enxertos sintéticos presentemente disponíveis são 3 a 10 vezes menos resistentes à pressão do que a artéria natural e proporcionalmente estão mais sujeitos a trombose do que a artéria natural. □ método das técnicas anteriores para compensação deste desajustamento da resistência à pressão consiste em utilizar um material de enxerto com um diâmetro maior do que a artéria natural adjacente. Esta técnica, contudo, acarretou problemas adicionais. A velocidade do sanque é menor através do segmento de enxerto com um diâmetro maior. Por isso, existe uma menor força de cisalhamento na parede do enxerto. Nestas condiçSes, são mais prováveis o depósito de plaquetas e de fibrina com subsequente trombose. Pe?lo contrário, porque o material SIS demonstra uma tão elevada resistência à pressão, os enxertos de SIS isodiamétricos podem ser utilizados sem a ocorrência desses problemas.
ponto de poderia pressão tubular en ::er to presente material de enxerto de SIS revelou ter pressão de rebentamento muito para além do que encontrar fisiológicamente. Foi realizado um teste de rebentamento ligando um segmento de enxerto de a cilindros com 25 mm de diâmetro e pressurizando com gás azoto com uma taxa de fluxo constante. Fo um de
SIS o
ram
BAD ORIGINAL usadas duas taxas de fluxo. Com a taxa de fluxo mais baixa,, a pressão inicialmente aumentou para em seguida cair e estabilizou à medida que a saida de gás através da parede do enxerta se equilibrou com a entrada de qás. Com a taxa de fluxo mais elevada, a pressão subiu imediatamente até condiçoes de rebentamento a aproximadamente 400 mm Hg, indicando que o material de enxerto pode fácilmente suportar as pressões pulsáteis contínuas encontradas na utilização de enxertos vasculares fisiológicamente normais.
EXEMPLOS
Exemplo 1. Submucosa do Intestino Delgado como um Enxerto Arterial de Grande Diâmetro
Foi realizada uma série de experiências que testaram a capacidade de três diferentes configuraçSes do intestino delgado para servirem como enxertos vasculares na aorta infrarenal do cão. A primeira experiência utilizou um segmento de jejuno não invertido, com a espessura total, ou com um fornecimento neurovascular mesentérico intacto ou com um segmento isolado, livre, como o material de enxerta. A mucosa intestinal constituiu a interface sangue-enxerto. Os 4 cães desta experiência morreram todos no espaço de 13 horas após a cirurgia por trombose do segmento do enxerto e hemorragia a partir das linhas de sutura.
isolado e in ter face enxerto
A segunda experiência utilizou um segmento de jejuno invertido como enxerto com a. túnica serosa, servindo de s a n que- en x e r to. U t i 1 i z a r am—se 2 c ã e s n e s t a e pe r i ê n c i a. „ no primeiro cão ficou trombosado 4 horas após a cirurgia, e o segundo cão morreu de hemorragia aguda no sítio da anastomose proxima.l 4 dias- após a cirurgia.
BAD ORIGINAL
- 13 A terceira experiência testou a. utilização de apenas uma porção da parede intestinal como material de enxerto. Foi recolhido de cada. cão um segmento livre da porção superior de jejuno e então a maior parte da mucosa foi removida raspando rudemente a superfície luminal com um cabo de bisturi. Pelo mesmo processo,, foram então removidas a serosa e a túnica muscularis. □ tecido gue permaneceu após esta manipulação aparentemente brutal do segmento do intestino era constituído por uma secção da submucosa e de mucosa basilar com ΙΟΘμ de espessura. Este enxerto foi então colocado na aorta infrarenal de 15 cães tendo tido im êxito notável. Os resumidos a seguir resultados desta terceira experiência são
Treze dos 15 cães mantiveram enxertos patentes até à altura em que foram sacrificados. Onze cães foram sacrificadas em vários tempos após a cirurgia variando entre 4 dias e 1 ano. animais não revelaram quaisquer sinais de infecção, formação aneurisma ou trombose do enxerto. A insu
Os de do enxerto observada em dois cães foi causada por erro técnico, incluindo má colocação dos agrafos de ligação metálicos e má técnica de anastomose. Dois animais permanecem vivos na altura da elaboração deste texto os quais estão sendo monitorizados para informação sobre a patencia do enxerto a longo prazo.
A patencia dos enxertos foi verificada por meio de radiografia de contraste positiva no espaço de quatro a sete dias após a. cirurgia, e em seguida cada 6 a. 8 semanas. Além disso, a patencia do enxerto foi monitorizada clinicamente observando a presença, de um pulso femural forte e a. inexistência de edema das patas posteriores.
Onze dos cães que mantiveram enxertos patentes foram sacrificados em vários intervalas de tempo após a cirurgia (4,, 7,
BAD ORIGINAL e 14 dias, e 9, 11, 13, 17, 26, 44, e 52 semanas). Imediatamente antes de serem sacrificados, os animais foram submetidos a uma angiografia adicional para confirmar a patencia do enxerta e para proporcionar uma radiografia comparativa para avaliação da dilatação, estenose e formação de aneurisma no enxerto. Os orce cães revelaram todos uma patencia completa sem evidencia de alterações luminais prejudiciais.
A observação macroscópica destes segmentos de enxerto revelou uma superfície luminal brilhante com areas vermelhas e brancas combinadas ao acaso e sem evidencia de formação de trombos» Verificou-se a acumulação de um tecido conjuntivo dura circundante o qual se apresentou em confluência com a parede do enxerta. Todos os especimens examinadas antes de b meses após a cirurgia não revelaram qualquer evidência, de crescimento celular endotelial sabre a superfície do enxerto. A superfície destes enxertos ficou, coberta por uma camada plana, moderadamente densa e organizada de colagénio,
O exame histopatológico de especimens às 26, 44 e 52 semanas revelou a existência de células do tipo endotelial que cobriam parcialmente uma camada delgada (aproximadamente 500p) de fibrina densamente organizada. Toda a tecido se encontrava infiltrado com capilares cheis de sangue, e o bordo externo do material de enxerta original não se conseguia distinguir do tecido conjuntivo envolvente. D exame por microscopia electróníca de varredura da superfície luminal revelou uma camada de células achatadas, que não se consegue distinguir das células endote— liais, com pseudcpodia alongada. A avaliação por microscopia electróníca do transmissão destes- segmentos de enxerto também sugeriram a presença de células endoteliais cobrindo a superfície luminal ·. Além disso, a presença de Factor VIII: Antigénio Afim, detectado por coloração imunof lu.orescen te, suqeriu. também a
BAD ORJG/NAL '
origem endotelial destas células de. superfície luroinal do enxerto. D material do enxerto foi também testado· quanto à presença de células endoteliais fazendo um ensaio quanto à presença de factor relaxante derivado do· endotelio. A acetilcolina foi aplicada à superfície dos especíroens de enxerta e a efluente foi recolhido. 0 efluente revelou, através de observação do relaxamento do músculo liso numa preparação de aorta da ratazana, conter factor relaxante derivado do endotelio.
A pressão sanguínea na porção cefálica, na porção distai e no interior do enxerte· de SIS foi determinada em cada um dos IO cães sacrifiçados. As pressões revelaram-se idênticas nas 3 localizações em cada um dos cães, reflectindo uma inexistência de efeitos hemodinSmicos prejudiciais originados pelo material de enxerto SIS.
□ s parâmetros laboratoriais que se seguem foram medidos antes da cirurgia, um dia após a cirurgia, e em seguida em vários tempos adicionais durante meses subsequentes em todos os cães: hematócrito, tempo de protrombina, tempo de tromboplastina parcialmente activada, contagem de plaquetas, fórmula e contagem completa, e um perfil químico abreviado do soro. Os resultados obtidos com estes exames laboratoriais em todos os tempos revelaram que os animais estavam normais. Administrou-se a estes at.nimais um tratamento com doses baixas de heparina (óúO unidades IV) durante o processo cirúrgico, mas não se lhes administrou anticoagulante durante o período pós-operatório. A não existência de quaisquer alterações nos testes de coagulação e nas contaqens de plaquetas foi particularmente encorajante tendo em conta o sistema de coagulação rela.tivamente hiperactivo cio cão em comparação com o do homem.
BAD ORIGINAL
Exemplo 2. Submucosa do Intestino Delgado oomo um Enxerto
Arterial de Pequeno Diâmetro
Esta experiência envolveu a implantação em dezoito cães de um total de 3ó enxertos tanto na artéria femoral como na artéria carótida. Trinta e três dos trinta e seis enxertos permaneceram patentes. Foram feitas medições 1aboratoriais nestes animais idênticas às do primeiro estudo não tendo sido observadas quaisquer anomalias. Além disso, utilizou-se formação de imagem por ultrasons em 2 dimensões convencionais para medir a patencia. e o diâmetro do vaso em corte transversal.
exame anátomopatológico do tecido do enxerto a partir de um cão sacrificado quatro dias após cirurgia revelou uma superfície luminal não trombótica e uma anastomose proximal moderadamente estenótica. D exame histológico revelou a presença precoce de capilares cheios de sangue na parede do enxerto, o que representa uma defesa natural do organismo em relação à. infecção. Cinco destes doentes permaneceram vivos na altura da elaboração deste texto para posterior avaliação. D cão com maior sobrevivência neste estudo tem agora 7 meses de vida após cirurgia.
Exemplo 3, Submucosa do Intestino Delgado como um Enxerto Venoso
Lava pu cães e homem ') tenham v a m e n t e en xerto
Nesta experiência, o enxerto SIS foi colocado na veia sterior (análoga à veia cava inferior no homem) de dois na veia cava anterior (análoga à veia cava superior no de cinco cães. Embora. os enxertos na veia cava posterior permanecido patentes durante apenas 11 e 14 dias respecti, o exame anátomopatológico revelou gue o insucesso dos s se ficou a dever a erros técnicos em que o sítio da bad ORSGíNAL anastoroose inferior ficou, estenosado (S ω de diâmetro em comparação com os IA mm de diâmetro adjacente na veia cava natural e no enxerto proximal). Além disso, as superfícies luminais de ambos os enxertos encontravam-se cobertas por um pseudoepitelio não trombótico composto por fibrina firmemente unida e por tecido conjuntivo colagénio imaturo.
Os enxertos na veia cava anterior permaneceram patentes até se sacrificarem três dos cães nos dias 7, 14 e 21 respectivamente, após cirurgia. Dois dos cães permanecem vivos na altura da elaboração deste texto com enxertos patentes às 7 semanas após a cirurgia. A linha de sutura proximal nos três cães revelou evidência de trombose precoce no local em que se tinha invertido uma beira do enxerto o que estava, na origem de um fluxo sanguíneo turbulento, mas a restante porção do enxerto mostravase não trombótico. Além disso, os exames anatomopatológico e histológico revelaram que o enxerto se encontrava revestido por uma superfície vermelha lisa, brilhante com um aspecto idêntico ao cios enxertos anteriores estudados em experiências prévias.
BAD ORl&NM*.
Exempla 4 Submucosa do Intestino Delgado como um ftloenxerto Arterial
SIS tem sido utilizado como um aloenxerto de grande diâmetro na aorta do cão. Os aloenxertos foram realizados do mesmo modo que o descrito anteriormente para o nosso estudo de enxertos aorticos. Na altura da elaboração deste texto os animais do teste têm apenas 8 semanas de vida após a cirurgia, mas não apresentam quaisquer sinais de trombose, infecção ou formação de aneurisma no enxerto (como é documentado por angiogramas).
Ε xem pio 5. Submucosa do Intestino Delgado como um
Heteroenxerto Arterial □ SIS tem sido utilizado como um heteroenxerto no cão. 0 enxerto com SIS de origem felina foi preparado de acordo com os processos aqui anteriormente descritos e foi colocado num cão. Na altura da elaboração deste texto, o animal do teste tinha duas semanas de vida após a cirurgia e não apresentava quaisquer sinais prejudiciais.
BAD ORIGINALj
Claims (1)
- REIVINDICAÇÕES:lê - Composição de enxerto de tecido carac terizada por compreender a túnica submucosa, a muscularis mucosa e o stratum compactum da túnica mucosa de um segmento do tecido intestinal de um vertebrado de sangue quente, sendo a túnica submucosa, muscularis mucosa e statum compactum deslaminados da túnica muscularis e da porção luminal da túnica mucosa do referido segmento do tecido intestinal.22 - Composição do enxerto de tecido Reivindicação 1 caractecizada por o segmento do de acordo com a tecido intestinal ser retirado do intestino delgado.32 - Composição de reivindicação 2 caracterizada ser retirado do jejuno.enxerto de tecido por o segmento de de acordo com a tecido intestinal42 - Composição de enxerto de tecido de acordo com a reivindicação 1 csracteriazda por ser formada num cilindro tendo um diâmetro dc> lume pré—determinado e suturada ao longo do comprimento do cilindro.52 - Composição de enxerto de tecido de acordo com a reivindicação 4 caracterizada pctr o stratum compactum formar a superfície luminal do cilindro,.62 — Composição do enxerto de tecido de acordo com a reivindicação 2 caracterizada por ser formada num cilindro tendo um diâmetro de lume pré—determinado e suturada ao longo do comprimento do cilindro,.BAD ORIGINA7â - Composição do enxerta de teoido de acorda com reivindicação 6 caracterizada por o stratum compactum formar superfície luminal do cilindro.Lisboa, 7 de Julho de 198?J. PEREIRA DA CRUZ Agmts Oficial Ja Prepriíóiah In4usíri»l VlCTCft CORD®N. io-a.1200 LISBOA1.·RUABAD ORIGINAL ; jáFOLHA ÚNICA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/217,299 US4902508A (en) | 1988-07-11 | 1988-07-11 | Tissue graft composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT91096A PT91096A (pt) | 1990-02-08 |
| PT91096B true PT91096B (pt) | 1994-12-30 |
Family
ID=22810477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT91096A PT91096B (pt) | 1988-07-11 | 1989-07-07 | Composicao de enxerto de tecido |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4902508A (pt) |
| EP (1) | EP0424463B1 (pt) |
| JP (1) | JP2539934B2 (pt) |
| KR (1) | KR0131821B1 (pt) |
| CN (1) | CN1018893B (pt) |
| AR (1) | AR244539A1 (pt) |
| AT (1) | ATE112963T1 (pt) |
| AU (1) | AU613499B2 (pt) |
| BR (1) | BR8907538A (pt) |
| CA (1) | CA1335432C (pt) |
| CH (2) | CH681506A5 (pt) |
| DE (1) | DE68918943T2 (pt) |
| DK (1) | DK175719B2 (pt) |
| ES (1) | ES2019146A6 (pt) |
| FI (1) | FI910113A0 (pt) |
| HU (1) | HU207448B (pt) |
| IE (1) | IE67279B1 (pt) |
| IL (1) | IL90622A (pt) |
| MX (1) | MX171671B (pt) |
| NZ (1) | NZ229797A (pt) |
| OA (1) | OA09633A (pt) |
| PH (1) | PH26921A (pt) |
| PT (1) | PT91096B (pt) |
| WO (1) | WO1990000395A1 (pt) |
| ZA (1) | ZA894551B (pt) |
Families Citing this family (636)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171338B1 (en) * | 1988-11-10 | 2001-01-09 | Biocon, Oy | Biodegradable surgical implants and devices |
| US5281422A (en) * | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
| CA2131902C (en) * | 1992-03-13 | 2004-08-03 | Atrium Medical Corporation | Controlled porosity expanded polytetrafluoroethylene products and fabrication |
| US5800537A (en) | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
| EP0656939B1 (en) * | 1992-08-07 | 2004-03-31 | TEI Biosciences, Inc. | Production of graft tissue from extracellular matrix |
| US5300306A (en) * | 1992-09-29 | 1994-04-05 | Alvarado Carlos A | Tissue-equivalent membrane from bovine esophageal tissue |
| US5641518A (en) * | 1992-11-13 | 1997-06-24 | Purdue Research Foundation | Method of repairing bone tissue |
| US5352463A (en) * | 1992-11-13 | 1994-10-04 | Badylak Steven F | Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor |
| US6653291B1 (en) | 1992-11-13 | 2003-11-25 | Purdue Research Foundation | Composition and method for production of transformed cells |
| US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
| US5763416A (en) * | 1994-02-18 | 1998-06-09 | The Regent Of The University Of Michigan | Gene transfer into bone cells and tissues |
| US5962427A (en) * | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
| US6334872B1 (en) * | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
| US5942496A (en) * | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
| US6074840A (en) * | 1994-02-18 | 2000-06-13 | The Regents Of The University Of Michigan | Recombinant production of latent TGF-beta binding protein-3 (LTBP-3) |
| US20020193338A1 (en) * | 1994-02-18 | 2002-12-19 | Goldstein Steven A. | In vivo gene transfer methods for wound healing |
| ATE250901T1 (de) * | 1994-02-18 | 2003-10-15 | Organogenesis Inc | Bioumbaubare collagentransplantat prothese |
| US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| EP1217101B8 (en) | 1994-04-29 | 2006-02-01 | Boston Scientific Scimed, Inc. | Stent with collagen |
| US6475232B1 (en) * | 1996-12-10 | 2002-11-05 | Purdue Research Foundation | Stent with reduced thrombogenicity |
| US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
| US5562946A (en) * | 1994-11-02 | 1996-10-08 | Tissue Engineering, Inc. | Apparatus and method for spinning and processing collagen fiber |
| US5709934A (en) * | 1994-11-22 | 1998-01-20 | Tissue Engineering, Inc. | Bipolymer foams having extracellular matrix particulates |
| US5891558A (en) * | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
| US6485723B1 (en) * | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
| US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
| EP0734736A1 (en) * | 1995-03-31 | 1996-10-02 | Toyo Boseki Kabushiki Kaisha | Medical device and method for producing the same |
| EP0820301B1 (en) * | 1995-04-07 | 2002-07-24 | Purdue Research Foundation | Tissue graft for urinary bladder reconstruction |
| US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
| US20020095218A1 (en) * | 1996-03-12 | 2002-07-18 | Carr Robert M. | Tissue repair fabric |
| US5733337A (en) | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
| US5711969A (en) * | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
| US5569273A (en) * | 1995-07-13 | 1996-10-29 | C. R. Bard, Inc. | Surgical mesh fabric |
| US5911942A (en) * | 1995-11-02 | 1999-06-15 | Tissue Engineering, Inc. | Method for spinning and processing collagen fiber |
| US5788625A (en) * | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
| US5755791A (en) * | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
| US5733868A (en) * | 1996-04-16 | 1998-03-31 | Depuy Orthopaedics, Inc. | Poly(amino acid) adhesive tissue grafts |
| US6299905B1 (en) | 1996-04-16 | 2001-10-09 | Depuy Orthopaedics, Inc. | Bioerodable polymeric adhesives for tissue repair |
| US5668288A (en) * | 1996-04-16 | 1997-09-16 | Depuy Orthopaedics, Inc. | Polyester ionomers for implant fabrication |
| US5730933A (en) * | 1996-04-16 | 1998-03-24 | Depuy Orthopaedics, Inc. | Radiation sterilization of biologically active compounds |
| US6171344B1 (en) | 1996-08-16 | 2001-01-09 | Children's Medical Center Corporation | Bladder submucosa seeded with cells for tissue reconstruction |
| DE69721021T2 (de) * | 1996-08-16 | 2004-03-18 | The Childern's Medical Center Corp., Boston | Blasenmukosa mit zellen für die rekonstruktion von geweben |
| US8716227B2 (en) * | 1996-08-23 | 2014-05-06 | Cook Biotech Incorporated | Graft prosthesis, materials and methods |
| US6666892B2 (en) * | 1996-08-23 | 2003-12-23 | Cook Biotech Incorporated | Multi-formed collagenous biomaterial medical device |
| CZ54899A3 (cs) * | 1996-08-23 | 1999-08-11 | Cook Biotech, Incorporated | Štěpová protéza, materiály s ní spojené a způsoby její výroby |
| US20020173806A1 (en) * | 1996-08-30 | 2002-11-21 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
| US20060025786A1 (en) * | 1996-08-30 | 2006-02-02 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
| EP1430899B1 (en) * | 1996-09-16 | 2010-07-07 | Purdue Research Foundation | Graft from submucosal intestinal tissue for repairing neurological tissue |
| DK0925067T3 (da) * | 1996-09-16 | 2004-05-03 | Purdue Research Foundation | Graft fra submucosavæv til reparation af neurologisk væv |
| US5902228A (en) * | 1996-10-11 | 1999-05-11 | Cornell Research Foundation, Inc. | Method and apparatus for support and tubularization of surgical grafts |
| DE69730039T2 (de) * | 1996-11-05 | 2005-07-14 | Purdue Research Foundation, West Lafayette | Herztransplantate |
| AU774634B2 (en) * | 1996-12-10 | 2004-07-01 | Purdue Research Foundation | Tubular submucosal graft constructs |
| US6099567A (en) * | 1996-12-10 | 2000-08-08 | Purdue Research Foundation | Stomach submucosa derived tissue graft |
| JP4638562B2 (ja) * | 1996-12-10 | 2011-02-23 | パーデュー・リサーチ・ファウンデーション | 脊椎動物肝臓組織由来の生物材料 |
| US6696270B2 (en) | 1996-12-10 | 2004-02-24 | Purdue Research Foundation | Gastric submucosal tissue as a novel diagnostic tool |
| WO1998025546A1 (en) * | 1996-12-10 | 1998-06-18 | Cook Biotech, Inc. | Tubular grafts from purified submucosa |
| JP4046358B2 (ja) | 1996-12-10 | 2008-02-13 | パーデュー・リサーチ・ファウンデーション | 粘膜下組織抽出物 |
| EP1014887B1 (en) | 1996-12-10 | 2006-04-19 | Purdue Research Foundation | Stent with reduced thrombogenicity |
| CA2269989A1 (en) * | 1996-12-10 | 1998-06-18 | Purdue Research Foundation | Submucosal tissue inhibition of neoplastic cell growth |
| US6126686A (en) * | 1996-12-10 | 2000-10-03 | Purdue Research Foundation | Artificial vascular valves |
| EP1007673B1 (en) | 1997-07-30 | 2008-12-17 | Emory University | Novel bone mineralization proteins, dna, vectors, expression systems |
| US7923250B2 (en) | 1997-07-30 | 2011-04-12 | Warsaw Orthopedic, Inc. | Methods of expressing LIM mineralization protein in non-osseous cells |
| DK1011699T3 (da) * | 1997-09-11 | 2002-03-11 | Purdue Research Foundation | Galactosidase-modificeret submucosavæv |
| US6254627B1 (en) * | 1997-09-23 | 2001-07-03 | Diseno Y Desarrollo Medico S.A. De C.V. | Non-thrombogenic stent jacket |
| AU739276B2 (en) | 1997-09-24 | 2001-10-11 | Ethicon Inc. | ACL fixation pin and method |
| US6485969B1 (en) | 1997-12-23 | 2002-11-26 | Purdue Research Foundation | Biomaterial derived from follicle basement membranes |
| US7070607B2 (en) * | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
| AU743808B2 (en) | 1998-02-27 | 2002-02-07 | Purdue Research Foundation | Submucosa gel compositions |
| US7452371B2 (en) * | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
| AU753773B2 (en) * | 1998-06-05 | 2002-10-31 | Organogenesis Inc. | Bioengineered vascular graft prostheses |
| CA2334228C (en) * | 1998-06-05 | 2010-09-28 | Organogenesis Inc. | Bioengineered vascular graft support prostheses |
| EP1082057B1 (en) * | 1998-06-05 | 2009-02-25 | Organogenesis Inc. | Bioengineered tubular graft prostheses |
| CA2334364C (en) * | 1998-06-05 | 2011-01-04 | Organogenesis Inc. | Bioengineered flat sheet graft prostheses |
| US6933326B1 (en) | 1998-06-19 | 2005-08-23 | Lifecell Coporation | Particulate acellular tissue matrix |
| US6458109B1 (en) * | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
| WO2000032254A1 (en) * | 1998-12-01 | 2000-06-08 | Purdue Research Foundation | Method for vocal cord reconstruction |
| US8882850B2 (en) * | 1998-12-01 | 2014-11-11 | Cook Biotech Incorporated | Multi-formed collagenous biomaterial medical device |
| GB2361187A (en) * | 1998-12-01 | 2001-10-17 | Purdue Research Foundation | Submucosa modulation of mammalian immune response |
| US6918396B1 (en) | 1998-12-01 | 2005-07-19 | Purdue Research Foundation | Method for vocal cord reconstruction |
| DK1051206T3 (da) * | 1998-12-01 | 2008-11-24 | Cook Biotech Inc | En multi-formet medicinsk anordning af kollagenbaseret biomateriale |
| EP1051116B8 (en) * | 1998-12-01 | 2009-06-10 | Washington University | Embolization device |
| US20020165611A1 (en) | 1998-12-22 | 2002-11-07 | Robert-Jan Enzerink | Graft material convenience package |
| US6179840B1 (en) | 1999-07-23 | 2001-01-30 | Ethicon, Inc. | Graft fixation device and method |
| US20020095157A1 (en) * | 1999-07-23 | 2002-07-18 | Bowman Steven M. | Graft fixation device combination |
| DE60041703D1 (de) * | 1999-08-06 | 2009-04-16 | Cook Biotech Inc | Rohrförmige transplantatkonstruktion |
| US6824533B2 (en) | 2000-11-29 | 2004-11-30 | Hill-Rom Services, Inc. | Wound treatment apparatus |
| US6764462B2 (en) | 2000-11-29 | 2004-07-20 | Hill-Rom Services Inc. | Wound treatment apparatus |
| ATE342742T1 (de) | 1999-12-22 | 2006-11-15 | Acell Inc | Zusammensetzung zur geweberegeneration |
| US20040043006A1 (en) * | 2002-08-27 | 2004-03-04 | Badylak Stephen F. | Tissue regenerative composition |
| US6579538B1 (en) | 1999-12-22 | 2003-06-17 | Acell, Inc. | Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof |
| US6576265B1 (en) * | 1999-12-22 | 2003-06-10 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
| US6461364B1 (en) * | 2000-01-05 | 2002-10-08 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
| US6391048B1 (en) * | 2000-01-05 | 2002-05-21 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
| US7842068B2 (en) * | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
| US8758400B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
| US9579091B2 (en) * | 2000-01-05 | 2017-02-28 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
| US7635390B1 (en) * | 2000-01-14 | 2009-12-22 | Marctec, Llc | Joint replacement component having a modular articulating surface |
| EP1254479A1 (en) | 2000-01-18 | 2002-11-06 | XROS, Inc., Nortel Networks | Wafer bonding techniques to minimize built-in stress of silicon microstructures and micro-mirrors |
| US6866686B2 (en) * | 2000-01-28 | 2005-03-15 | Cryolife, Inc. | Tissue graft |
| WO2001054625A1 (en) | 2000-01-31 | 2001-08-02 | Cook Biotech Incorporated | Stent valves and uses of same |
| DE60127530T2 (de) | 2000-02-03 | 2007-12-13 | Cook Inc., Bloomington | Implantierbare vaskuläre vorrichtung |
| DE60121141T2 (de) * | 2000-03-09 | 2007-05-31 | Design & Performance - Cyprus Ltd. | Stent mit hüllenbefestigungen |
| DE60136925D1 (de) | 2000-05-04 | 2009-01-22 | Univ Oregon Health & Science | Endovaskulärer stent- graft |
| US7910791B2 (en) * | 2000-05-22 | 2011-03-22 | Coffey Arthur C | Combination SIS and vacuum bandage and method |
| US7410637B2 (en) * | 2000-06-20 | 2008-08-12 | Phycotransgenics, Llc | Transgenic algae for delivering antigens to an animal |
| US6638312B2 (en) * | 2000-08-04 | 2003-10-28 | Depuy Orthopaedics, Inc. | Reinforced small intestinal submucosa (SIS) |
| US8366787B2 (en) | 2000-08-04 | 2013-02-05 | Depuy Products, Inc. | Hybrid biologic-synthetic bioabsorbable scaffolds |
| AU8800901A (en) * | 2000-09-08 | 2002-03-22 | James E Coleman | Surgical stapler |
| EP1320390A2 (en) * | 2000-09-18 | 2003-06-25 | Organogenesis Inc. | Bioengineered flat sheet graft prosthesis and its use |
| US6626918B1 (en) * | 2000-10-06 | 2003-09-30 | Medical Technology Group | Apparatus and methods for positioning a vascular sheath |
| US6855135B2 (en) * | 2000-11-29 | 2005-02-15 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
| US6685681B2 (en) * | 2000-11-29 | 2004-02-03 | Hill-Rom Services, Inc. | Vacuum therapy and cleansing dressing for wounds |
| DE10060443A1 (de) * | 2000-11-29 | 2002-06-06 | Biotronik Mess & Therapieg | Stent aus menschlichem oder tierischem Gewebe |
| US7905900B2 (en) * | 2003-01-30 | 2011-03-15 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
| US8690910B2 (en) | 2000-12-07 | 2014-04-08 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
| US7806904B2 (en) * | 2000-12-07 | 2010-10-05 | Integrated Vascular Systems, Inc. | Closure device |
| US7211101B2 (en) * | 2000-12-07 | 2007-05-01 | Abbott Vascular Devices | Methods for manufacturing a clip and clip |
| US6623510B2 (en) * | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
| AU2002245092A1 (en) * | 2000-12-08 | 2002-07-30 | Todd M. Boyce | Implant for orthopedic applications |
| US6752831B2 (en) * | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
| CA2365376C (en) * | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US6852330B2 (en) * | 2000-12-21 | 2005-02-08 | Depuy Mitek, Inc. | Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US6599323B2 (en) * | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
| US20030211793A1 (en) * | 2001-03-05 | 2003-11-13 | Eugene Bell | Injectable bio-compatible material and methods of use |
| JP2004529711A (ja) * | 2001-05-07 | 2004-09-30 | クロスカート インコーポレイテッド | 粘膜下異種移植片 |
| US8740987B2 (en) * | 2001-06-04 | 2014-06-03 | Warsaw Orthopedic, Inc. | Tissue-derived mesh for orthopedic regeneration |
| IES20010547A2 (en) * | 2001-06-07 | 2002-12-11 | Christy Cummins | Surgical Staple |
| US20070038244A1 (en) * | 2001-06-08 | 2007-02-15 | Morris Edward J | Method and apparatus for sealing access |
| US7993365B2 (en) | 2001-06-08 | 2011-08-09 | Morris Innovative, Inc. | Method and apparatus for sealing access |
| CA2448900C (en) * | 2001-06-08 | 2011-05-17 | Morris Innovative Research, Inc. | Method and apparatus for sealing access |
| US20060004408A1 (en) * | 2001-06-08 | 2006-01-05 | Morris Edward J | Method and apparatus for sealing access |
| CA2452033C (en) * | 2001-06-28 | 2011-11-08 | Cook Biotech Incorporated | Graft prosthesis devices containing renal capsule collagen |
| AU2002320182B2 (en) | 2001-06-29 | 2008-02-21 | Cook Biotech Incorporated | Porous sponge matrix medical devices and methods |
| AU2002354915B8 (en) * | 2001-07-16 | 2008-04-17 | Depuy Products, Inc. | Porous extracellular matrix scaffold and method |
| US8025896B2 (en) * | 2001-07-16 | 2011-09-27 | Depuy Products, Inc. | Porous extracellular matrix scaffold and method |
| US7819918B2 (en) * | 2001-07-16 | 2010-10-26 | Depuy Products, Inc. | Implantable tissue repair device |
| JP2005515802A (ja) * | 2001-07-16 | 2005-06-02 | デピュイ・プロダクツ・インコーポレイテッド | 混成生物/合成品型多孔質細胞外基質支持骨格 |
| EP1416888A4 (en) * | 2001-07-16 | 2007-04-25 | Depuy Products Inc | DEVICE AND METHOD FOR REGENERATING THE MENISCUS |
| AU2002316696B2 (en) * | 2001-07-16 | 2007-08-30 | Depuy Products, Inc. | Cartilage repair and regeneration scaffold and method |
| WO2003007805A2 (en) | 2001-07-16 | 2003-01-30 | Depuy Products, Inc. | Cartilage repair apparatus and method |
| US7163563B2 (en) * | 2001-07-16 | 2007-01-16 | Depuy Products, Inc. | Unitary surgical device and method |
| WO2003007786A2 (en) * | 2001-07-16 | 2003-01-30 | Depuy Products, Inc. | Porous delivery scaffold and method |
| EP1416878A4 (en) | 2001-07-16 | 2007-04-18 | Depuy Products Inc | BIOLOGICAL / SYNTHETIC BIOABSORBABLE HYBRID EQUIPMENT |
| AU2002322567B2 (en) | 2001-07-16 | 2007-09-06 | Depuy Products, Inc. | Devices form naturally occurring biologically derived |
| US7833283B2 (en) * | 2001-08-16 | 2010-11-16 | Purdue Research Foundation | Material and method for promoting tissue growth |
| US7622129B1 (en) | 2002-08-05 | 2009-11-24 | Purdue Research Foundation | Nano-structured polymers for use as implants |
| US7708741B1 (en) | 2001-08-28 | 2010-05-04 | Marctec, Llc | Method of preparing bones for knee replacement surgery |
| US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
| US6702835B2 (en) * | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
| US6776784B2 (en) * | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
| US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
| US20090054912A1 (en) * | 2001-09-06 | 2009-02-26 | Heanue Taylor A | Systems and Methods for Treating Septal Defects |
| US20070112358A1 (en) * | 2001-09-06 | 2007-05-17 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
| US20060052821A1 (en) * | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
| EP1450878A1 (en) * | 2001-10-11 | 2004-09-01 | Hill-Rom Services, Inc. | Waste container for negative pressure therapy |
| JP2005525140A (ja) * | 2001-10-26 | 2005-08-25 | クック・バイオテック・インコーポレーテッド | 網状構造を付与した医用移植片デバイス |
| WO2003043674A1 (en) * | 2001-11-16 | 2003-05-30 | Children's Medical Center Corporation ¨ | Augmentation of organ function |
| AU2002360695A1 (en) * | 2001-12-19 | 2003-07-09 | Nmt Medical, Inc. | Septal occluder and associated methods |
| US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
| US20030118560A1 (en) * | 2001-12-20 | 2003-06-26 | Kelly Sheila J. | Composite biocompatible matrices |
| WO2003057071A2 (en) * | 2001-12-26 | 2003-07-17 | Hill-Rom Services, Inc. | Vacuum bandage packing |
| CA2468912A1 (en) * | 2001-12-26 | 2003-07-17 | Hill-Rom Services, Inc. | Vented vacuum bandage and method |
| AU2002359830A1 (en) * | 2001-12-26 | 2003-07-24 | Hill-Rom Services, Inc. | Wound vacuum therapy dressing kit |
| AU2003202264A1 (en) * | 2002-01-11 | 2003-07-30 | Clarian Health Partners, Inc. | Composition and method for inhibiting hypersensitivity |
| AU2003202261A1 (en) * | 2002-01-11 | 2003-07-30 | Purdue Research Foundation | Biomaterial derived from vertebrate liver tissue |
| CA2471871A1 (en) * | 2002-01-14 | 2003-07-24 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure method and device |
| US6749621B2 (en) | 2002-02-21 | 2004-06-15 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
| US20030171801A1 (en) * | 2002-03-06 | 2003-09-11 | Brian Bates | Partially covered intraluminal support device |
| US20100254900A1 (en) * | 2002-03-18 | 2010-10-07 | Campbell Phil G | Biocompatible polymers and Methods of use |
| US8529956B2 (en) * | 2002-03-18 | 2013-09-10 | Carnell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
| WO2003082076A2 (en) * | 2002-03-25 | 2003-10-09 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
| US6939369B2 (en) * | 2002-04-03 | 2005-09-06 | Cook Incorporated | Intraluminal graft assembly and vessel repair system |
| AU2002359824A1 (en) | 2002-04-10 | 2003-10-27 | Hill-Rom Services, Inc. | Access openings in vacuum bandage |
| WO2003088844A1 (en) | 2002-04-15 | 2003-10-30 | Cook Biotech Incorporated | Apparatus and method for producing a reinforced surgical staple line |
| US9492267B2 (en) | 2002-05-02 | 2016-11-15 | Cook Biotech Incorporated | Cell-seeded extracellular matrix grafts |
| WO2003092604A2 (en) * | 2002-05-02 | 2003-11-13 | Purdue Research Foundation | Vascularization enhanced graft constructs |
| JP2005524426A (ja) * | 2002-05-02 | 2005-08-18 | パーデュー・リサーチ・ファウンデーション | 血管新生が促進された移植片構成物 |
| CN1713861A (zh) * | 2002-05-02 | 2005-12-28 | 普渡研究基金会 | 血管化增强的移植构造物 |
| US20040117004A1 (en) * | 2002-05-16 | 2004-06-17 | Osborne Thomas A. | Stent and method of forming a stent with integral barbs |
| US7828839B2 (en) * | 2002-05-16 | 2010-11-09 | Cook Incorporated | Flexible barb for anchoring a prosthesis |
| AU2003243334A1 (en) * | 2002-05-29 | 2003-12-19 | Cook Incorporated | Multi-piece prosthesis deployment apparatus |
| US20040098042A1 (en) * | 2002-06-03 | 2004-05-20 | Devellian Carol A. | Device with biological tissue scaffold for percutaneous closure of an intracardiac defect and methods thereof |
| US7850709B2 (en) | 2002-06-04 | 2010-12-14 | Abbott Vascular Inc. | Blood vessel closure clip and delivery device |
| WO2003103476A2 (en) | 2002-06-05 | 2003-12-18 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure device with radial and circumferential support |
| US7238198B2 (en) * | 2002-06-26 | 2007-07-03 | Cook Incorporated | Stent-graft fastening |
| US7160326B2 (en) * | 2002-06-27 | 2007-01-09 | Depuy Products, Inc. | Method and apparatus for implantation of soft tissue implant |
| US20040166169A1 (en) * | 2002-07-15 | 2004-08-26 | Prasanna Malaviya | Porous extracellular matrix scaffold and method |
| JP2006501884A (ja) * | 2002-08-12 | 2006-01-19 | オステオテック,インコーポレイテッド | 骨−ポリマー複合材料の合成 |
| EP2517674B1 (en) | 2002-08-15 | 2016-03-16 | Cook Medical Technologies LLC | Implantable vascular device |
| US7550004B2 (en) * | 2002-08-20 | 2009-06-23 | Cook Biotech Incorporated | Endoluminal device with extracellular matrix material and methods |
| WO2004018020A1 (en) | 2002-08-21 | 2004-03-04 | Hill-Rom Services, Inc. | Wound packing for preventing wound closure |
| US20060136047A1 (en) * | 2002-09-06 | 2006-06-22 | Obermiller F J | Tissue graft prosthesis devices containing juvenile or small diameter submucosa |
| US20040136968A1 (en) * | 2002-09-27 | 2004-07-15 | Verigen Ag | Autologous cells on a support matrix for tissue repair |
| US20040078090A1 (en) * | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
| US7824701B2 (en) * | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
| US7766820B2 (en) | 2002-10-25 | 2010-08-03 | Nmt Medical, Inc. | Expandable sheath tubing |
| US7682392B2 (en) * | 2002-10-30 | 2010-03-23 | Depuy Spine, Inc. | Regenerative implants for stabilizing the spine and devices for attachment of said implants |
| WO2004043508A1 (en) * | 2002-11-06 | 2004-05-27 | Nmt Medical, Inc. | Medical devices utilizing modified shape memory alloy |
| AU2003287689A1 (en) * | 2002-11-07 | 2004-06-03 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure with magnetic force |
| US7627373B2 (en) * | 2002-11-30 | 2009-12-01 | Cardiac Pacemakers, Inc. | Method and apparatus for cell and electrical therapy of living tissue |
| US20040158289A1 (en) * | 2002-11-30 | 2004-08-12 | Girouard Steven D. | Method and apparatus for cell and electrical therapy of living tissue |
| EP1567093B1 (en) * | 2002-12-04 | 2009-01-21 | Cook Incorporated | Method and device for treating aortic dissection |
| US20040191226A1 (en) * | 2002-12-04 | 2004-09-30 | Badylak Stephen F. | Method for repair of body wall |
| US20040187877A1 (en) * | 2002-12-04 | 2004-09-30 | Badylak Stephen F. | Method for repair of liver tissue |
| EP1572003B1 (en) * | 2002-12-09 | 2017-03-08 | W.L. Gore & Associates, Inc. | Septal closure devices |
| US20050251267A1 (en) * | 2004-05-04 | 2005-11-10 | John Winterbottom | Cell permeable structural implant |
| US9107751B2 (en) * | 2002-12-12 | 2015-08-18 | Warsaw Orthopedic, Inc. | Injectable and moldable bone substitute materials |
| EP1583487B1 (en) | 2003-01-14 | 2016-11-02 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
| US9125733B2 (en) | 2003-01-14 | 2015-09-08 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
| US8758398B2 (en) | 2006-09-08 | 2014-06-24 | Integrated Vascular Systems, Inc. | Apparatus and method for delivering a closure element |
| US8202293B2 (en) | 2003-01-30 | 2012-06-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
| US7857828B2 (en) * | 2003-01-30 | 2010-12-28 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
| US8905937B2 (en) * | 2009-02-26 | 2014-12-09 | Integrated Vascular Systems, Inc. | Methods and apparatus for locating a surface of a body lumen |
| US8821534B2 (en) | 2010-12-06 | 2014-09-02 | Integrated Vascular Systems, Inc. | Clip applier having improved hemostasis and methods of use |
| US8398656B2 (en) | 2003-01-30 | 2013-03-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
| JP2006516467A (ja) | 2003-02-04 | 2006-07-06 | オステオテック,インコーポレイテッド | 骨インプラントのためのポリウレタン |
| US7985414B2 (en) * | 2003-02-04 | 2011-07-26 | Warsaw Orthopedic, Inc. | Polyurethanes for osteoimplants |
| US20040176855A1 (en) * | 2003-03-07 | 2004-09-09 | Acell, Inc. | Decellularized liver for repair of tissue and treatment of organ deficiency |
| US20040175366A1 (en) * | 2003-03-07 | 2004-09-09 | Acell, Inc. | Scaffold for cell growth and differentiation |
| US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
| US7658747B2 (en) * | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
| WO2004082528A2 (en) | 2003-03-17 | 2004-09-30 | Cook Incorporated | Vascular valve with removable support component |
| US7993412B2 (en) * | 2003-03-27 | 2011-08-09 | Purdue Research Foundation | Nanofibers as a neural biomaterial |
| EP1610728B1 (en) * | 2003-04-01 | 2011-05-25 | Cook Incorporated | Percutaneously deployed vascular valves |
| FR2853394B1 (fr) * | 2003-04-03 | 2006-03-10 | Valeo Vision | Dispositif de projection pour vehicule automobile eclairant des points de portique |
| US20050222687A1 (en) * | 2004-04-02 | 2005-10-06 | Gordana Vunjak-Novakovic | Cartilage implant assembly and method for implantation |
| US7067123B2 (en) * | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| US20050064042A1 (en) * | 2003-04-29 | 2005-03-24 | Musculoskeletal Transplant Foundation | Cartilage implant plug with fibrin glue and method for implantation |
| US7488348B2 (en) * | 2003-05-16 | 2009-02-10 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| US20090291112A1 (en) * | 2003-05-16 | 2009-11-26 | Truncale Katherine G | Allograft osteochondral plug combined with cartilage particle mixture |
| US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| US7105001B2 (en) * | 2003-05-21 | 2006-09-12 | Mandelbaum Jon A | Surgical method and composition utilizing submucosal tissue to prevent incisional hernias |
| US20040260315A1 (en) * | 2003-06-17 | 2004-12-23 | Dell Jeffrey R. | Expandable tissue support member and method of forming the support member |
| CA2530490A1 (en) | 2003-06-25 | 2005-01-13 | Stephen F. Badylak | Conditioned matrix compositions for tissue restoration |
| US8226715B2 (en) * | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
| EP1651116B1 (en) * | 2003-07-14 | 2013-06-26 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
| US8480706B2 (en) * | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
| US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
| US7153324B2 (en) * | 2003-07-31 | 2006-12-26 | Cook Incorporated | Prosthetic valve devices and methods of making such devices |
| US10583220B2 (en) * | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
| ATE413898T1 (de) * | 2003-08-19 | 2008-11-15 | Nmt Medical Inc | Expandierbarer schleusenschlauch |
| US8021692B2 (en) | 2003-08-25 | 2011-09-20 | Cook Biotech Incorporated | Graft materials containing bioactive substances, and methods for their manufacture |
| GB2423934B (en) * | 2003-09-04 | 2007-11-28 | Cook Biotech Inc | Extracellular matrix composite materials, and manufacture and use thereof |
| US7645229B2 (en) * | 2003-09-26 | 2010-01-12 | Armstrong David N | Instrument and method for endoscopic visualization and treatment of anorectal fistula |
| JP4406649B2 (ja) * | 2003-10-10 | 2010-02-03 | ザ クリーブランド クリニック ファウンデイション | 相互接続モジュール関連適用の管腔内プロテーゼ |
| US8043357B2 (en) | 2003-10-10 | 2011-10-25 | Cook Medical Technologies Llc | Ring stent |
| AU2004279458B2 (en) * | 2003-10-10 | 2009-12-10 | Cook Incorporated | Fenestrated stent grafts |
| US8734501B2 (en) | 2003-10-10 | 2014-05-27 | Cook Medical Technologies Llc | Composite stent graft |
| US6976679B2 (en) * | 2003-11-07 | 2005-12-20 | The Boeing Company | Inter-fluid seal assembly and method therefor |
| US7316822B2 (en) * | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
| US20050125033A1 (en) * | 2003-12-04 | 2005-06-09 | Mcnally-Heintzelman Karen M. | Wound closure apparatus |
| US8389588B2 (en) * | 2003-12-04 | 2013-03-05 | Kensey Nash Corporation | Bi-phasic compressed porous reinforcement materials suitable for implant |
| US20050125015A1 (en) * | 2003-12-04 | 2005-06-09 | Mcnally-Heintzelman Karen M. | Tissue-handling apparatus, system and method |
| US8133500B2 (en) * | 2003-12-04 | 2012-03-13 | Kensey Nash Bvf Technology, Llc | Compressed high density fibrous polymers suitable for implant |
| US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
| US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
| WO2005070302A1 (en) * | 2004-01-21 | 2005-08-04 | Cook Incorporated | Implantable graft to close a fistula |
| US8262694B2 (en) * | 2004-01-30 | 2012-09-11 | W.L. Gore & Associates, Inc. | Devices, systems, and methods for closure of cardiac openings |
| CA2554460A1 (en) * | 2004-02-09 | 2005-08-25 | Cook Biotech Incorporated | Stent graft devices having collagen coating |
| US8337545B2 (en) | 2004-02-09 | 2012-12-25 | Cook Medical Technologies Llc | Woven implantable device |
| US11395865B2 (en) * | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
| US8920443B2 (en) * | 2004-02-17 | 2014-12-30 | Cook Biotech Incorporated | Medical devices and methods useful for applying bolster material |
| US7840263B2 (en) * | 2004-02-27 | 2010-11-23 | Cardiac Pacemakers, Inc. | Method and apparatus for device controlled gene expression |
| EP1737349A1 (en) * | 2004-03-03 | 2007-01-03 | NMT Medical, Inc. | Delivery/recovery system for septal occluder |
| EP1734814B1 (en) | 2004-03-17 | 2015-01-21 | Revivicor, Inc. | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| US7449027B2 (en) * | 2004-03-29 | 2008-11-11 | Cook Incorporated | Modifying fluid flow in a body vessel lumen to promote intraluminal flow-sensitive processes |
| CA2560876A1 (en) * | 2004-03-29 | 2005-10-13 | Cook Biotech Incorporated | Medical graft products with differing regions and methods and systems for producing the same |
| US20050234509A1 (en) * | 2004-03-30 | 2005-10-20 | Mmt Medical, Inc. | Center joints for PFO occluders |
| US9498322B2 (en) * | 2004-03-31 | 2016-11-22 | Cook Medical Technologies Llc | Multi-portion endoluminal prosthesis |
| AU2005231781A1 (en) * | 2004-03-31 | 2005-10-20 | Cook Incorporated | ECM-based graft material |
| ATE491416T1 (de) * | 2004-03-31 | 2011-01-15 | Cook Inc | Stentablagevorrichtung |
| WO2005096989A1 (en) * | 2004-03-31 | 2005-10-20 | Cook Incorporated | Graft material and stent graft comprising extra collagen matrix and method of preparation |
| WO2005096988A1 (en) * | 2004-04-01 | 2005-10-20 | Cook Incorporated | A device for retracting the walls of a body vessel with remodelable material |
| US20050267524A1 (en) * | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
| US8137686B2 (en) | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US8221780B2 (en) * | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US8657881B2 (en) * | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
| US7922759B1 (en) * | 2004-04-22 | 2011-04-12 | Cook Medical Technologies Llc | Apparatus and methods for vascular treatment |
| US8361110B2 (en) * | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
| US7569233B2 (en) * | 2004-05-04 | 2009-08-04 | Depuy Products, Inc. | Hybrid biologic-synthetic bioabsorbable scaffolds |
| US20050249772A1 (en) * | 2004-05-04 | 2005-11-10 | Prasanna Malaviya | Hybrid biologic-synthetic bioabsorbable scaffolds |
| US8308760B2 (en) * | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
| US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
| JP2007535997A (ja) | 2004-05-07 | 2007-12-13 | エヌエムティー メディカル, インコーポレイティッド | 管状中隔オクルーダーの捕捉機構 |
| US7704268B2 (en) * | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
| IES20040368A2 (en) * | 2004-05-25 | 2005-11-30 | James E Coleman | Surgical stapler |
| US7764995B2 (en) | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
| CA2570142A1 (en) * | 2004-07-07 | 2006-02-09 | Cook Incorporated | Graft, stent graft and method for manufacture |
| AU2005267826A1 (en) * | 2004-07-30 | 2006-02-09 | Cook Biotech Incorporated | Graft with increased resistance to enzymatic degradation |
| US20060029633A1 (en) * | 2004-08-03 | 2006-02-09 | Arthrotek, Inc | Biological patch for use in medical procedures |
| US8257715B1 (en) | 2004-08-26 | 2012-09-04 | University Of Notre Dame | Tissue vaccines and uses thereof |
| US8764848B2 (en) * | 2004-09-24 | 2014-07-01 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
| US20090319045A1 (en) * | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| US20080220044A1 (en) * | 2007-03-06 | 2008-09-11 | Semler Eric J | Cancellous construct with support ring for repair of osteochondral defects |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| WO2006050459A2 (en) * | 2004-10-28 | 2006-05-11 | Cook Incorporated | Methods and systems for modifying vascular valves |
| US7513866B2 (en) * | 2004-10-29 | 2009-04-07 | Depuy Products, Inc. | Intestine processing device and associated method |
| US7458987B2 (en) * | 2004-10-29 | 2008-12-02 | Cook Incorporated | Vascular valves having implanted and target configurations and methods of preparing the same |
| US7905826B2 (en) * | 2004-11-03 | 2011-03-15 | Cook Incorporated | Methods for modifying vascular vessel walls |
| US8329202B2 (en) | 2004-11-12 | 2012-12-11 | Depuy Products, Inc. | System and method for attaching soft tissue to an implant |
| US7744621B2 (en) * | 2004-12-06 | 2010-06-29 | Cook Incorporated | Inflatable occlusion devices, methods, and systems |
| WO2006062976A2 (en) * | 2004-12-07 | 2006-06-15 | Cook Incorporated | Methods for modifying vascular vessel walls |
| US8874204B2 (en) * | 2004-12-20 | 2014-10-28 | Cardiac Pacemakers, Inc. | Implantable medical devices comprising isolated extracellular matrix |
| US7981065B2 (en) * | 2004-12-20 | 2011-07-19 | Cardiac Pacemakers, Inc. | Lead electrode incorporating extracellular matrix |
| US20060134071A1 (en) * | 2004-12-20 | 2006-06-22 | Jeffrey Ross | Use of extracellular matrix and electrical therapy |
| US8060219B2 (en) * | 2004-12-20 | 2011-11-15 | Cardiac Pacemakers, Inc. | Epicardial patch including isolated extracellular matrix with pacing electrodes |
| US7354627B2 (en) | 2004-12-22 | 2008-04-08 | Depuy Products, Inc. | Method for organizing the assembly of collagen fibers and compositions formed therefrom |
| US8066732B2 (en) * | 2004-12-30 | 2011-11-29 | Cook Incorporated | Inverting occlusion devices, methods, and systems |
| US8287583B2 (en) | 2005-01-10 | 2012-10-16 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
| US8128680B2 (en) * | 2005-01-10 | 2012-03-06 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
| US20070150051A1 (en) * | 2005-01-10 | 2007-06-28 | Duke Fiduciary, Llc | Vascular implants and methods of fabricating the same |
| US20060206139A1 (en) * | 2005-01-19 | 2006-09-14 | Tekulve Kurt J | Vascular occlusion device |
| US20060246033A1 (en) * | 2005-03-02 | 2006-11-02 | Cook Biotech Incorporated | Injectable bulking agent compositions |
| US8303647B2 (en) * | 2005-03-03 | 2012-11-06 | Cook Medical Technologies Llc | Medical valve leaflet structures with peripheral region receptive to tissue ingrowth |
| US20060257447A1 (en) * | 2005-03-09 | 2006-11-16 | Providence Health System | Composite graft |
| US9138445B2 (en) * | 2005-03-09 | 2015-09-22 | Cook Biotech Incorporated | Medical graft materials with adherent extracellular matrix fibrous mass |
| US7840266B2 (en) * | 2005-03-11 | 2010-11-23 | Cardiac Pacemakers, Inc. | Integrated lead for applying cardiac resynchronization therapy and neural stimulation therapy |
| WO2006102213A1 (en) | 2005-03-18 | 2006-09-28 | Nmt Medical, Inc. | Catch member for pfo occluder |
| US8454678B2 (en) * | 2005-03-19 | 2013-06-04 | Cook Biotech Incorporated | Prosthetic implants including ECM composite material |
| US8197534B2 (en) * | 2005-03-31 | 2012-06-12 | Cook Medical Technologies Llc | Valve device with inflatable chamber |
| US20060229670A1 (en) * | 2005-04-01 | 2006-10-12 | Bates Brian L | Method and a medical closure system for sealing a puncture |
| WO2006113501A1 (en) | 2005-04-13 | 2006-10-26 | The Cleveland Clinic Foundation | Endoluminal prosthesis |
| AU2006270499B2 (en) | 2005-04-29 | 2011-10-06 | Cook Biotech Incorporated | Fistula graft with deformable sheet-form material |
| CA2606445C (en) * | 2005-04-29 | 2014-09-16 | Cook Biotech Incorporated | Volumetric grafts for treatment of fistulae and related methods and systems |
| US20060251702A1 (en) * | 2005-05-05 | 2006-11-09 | Cook Biotech Incorporated | Implantable materials and methods for inhibiting tissue adhesion formation |
| US8518436B2 (en) * | 2005-05-16 | 2013-08-27 | Purdue Research Foundation | Engineered extracellular matrices |
| US8475512B2 (en) * | 2005-05-17 | 2013-07-02 | Cook Medical Technologies Llc | Prosthetic valve devices and methods of making and using such devices |
| US20060276883A1 (en) * | 2005-06-01 | 2006-12-07 | Cook Incorporated | Tapered and distally stented elephant trunk stent graft |
| US20080109058A1 (en) * | 2005-06-01 | 2008-05-08 | Cook Incorporated | Intraoperative Anastomosis Method |
| AU2006262178B2 (en) | 2005-06-21 | 2012-07-05 | Cook Biotech, Inc. | Implantable graft to close a fistula |
| US20060292227A1 (en) * | 2005-06-23 | 2006-12-28 | Mcpherson Timothy B | Extracellular matrix material particles and methods of preparation |
| US8926633B2 (en) | 2005-06-24 | 2015-01-06 | Abbott Laboratories | Apparatus and method for delivering a closure element |
| US20080312686A1 (en) * | 2005-07-01 | 2008-12-18 | Abbott Laboratories | Antimicrobial closure element and closure element applier |
| US8313497B2 (en) * | 2005-07-01 | 2012-11-20 | Abbott Laboratories | Clip applier and methods of use |
| US9271817B2 (en) * | 2005-07-05 | 2016-03-01 | Cook Biotech Incorporated | Tissue augmentation devices and methods |
| US8579936B2 (en) * | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
| US7850985B2 (en) * | 2005-07-05 | 2010-12-14 | Cook Biotech Incorporated | Tissue augmentation devices and methods |
| US7815926B2 (en) * | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
| WO2007014088A2 (en) * | 2005-07-25 | 2007-02-01 | Cook Incorporated | Intraluminal prosthesis and stent |
| US7595062B2 (en) | 2005-07-28 | 2009-09-29 | Depuy Products, Inc. | Joint resurfacing orthopaedic implant and associated method |
| CA2616865C (en) | 2005-07-28 | 2014-07-08 | Carnegie Mellon University | Biocompatible polymers and methods of use |
| US20070038299A1 (en) * | 2005-08-12 | 2007-02-15 | Arthrotek, Inc | Multilayer microperforated implant |
| US20070038295A1 (en) * | 2005-08-12 | 2007-02-15 | Cook Incorporated | Artificial valve prosthesis having a ring frame |
| US9456811B2 (en) * | 2005-08-24 | 2016-10-04 | Abbott Vascular Inc. | Vascular closure methods and apparatuses |
| US20070060895A1 (en) | 2005-08-24 | 2007-03-15 | Sibbitt Wilmer L Jr | Vascular closure methods and apparatuses |
| US8920442B2 (en) * | 2005-08-24 | 2014-12-30 | Abbott Vascular Inc. | Vascular opening edge eversion methods and apparatuses |
| US8771340B2 (en) * | 2005-08-25 | 2014-07-08 | Cook Medical Technologies Llc | Methods and devices for the endoluminal deployment and securement of prostheses |
| US8470022B2 (en) * | 2005-08-31 | 2013-06-25 | Cook Biotech Incorporated | Implantable valve |
| WO2007028052A2 (en) * | 2005-09-01 | 2007-03-08 | Cook Incorporated | Attachment of material to an implantable frame by cross-linking |
| US7846179B2 (en) * | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
| WO2007030433A2 (en) * | 2005-09-06 | 2007-03-15 | Nmt Medical, Inc. | Removable intracardiac rf device |
| US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
| US20070088388A1 (en) * | 2005-09-19 | 2007-04-19 | Opolski Steven W | Delivery device for implant with dual attachment sites |
| US8921109B2 (en) | 2005-09-19 | 2014-12-30 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
| US7503928B2 (en) * | 2005-10-21 | 2009-03-17 | Cook Biotech Incorporated | Artificial valve with center leaflet attachment |
| EP1948037A2 (en) * | 2005-10-24 | 2008-07-30 | NMT Medical, Inc. | Radiopaque bioabsorbable occluder |
| US7563277B2 (en) * | 2005-10-24 | 2009-07-21 | Cook Incorporated | Removable covering for implantable frame projections |
| US8778360B2 (en) * | 2005-10-27 | 2014-07-15 | University Of Notre Dame | Extracellular matrix cancer vaccine adjuvant |
| US8802113B2 (en) * | 2005-10-27 | 2014-08-12 | University Of Notre Dame | Extracellular matrix cancer vaccine adjuvant |
| US8778362B2 (en) | 2005-10-27 | 2014-07-15 | University Of Notre Dame | Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof |
| US9308252B2 (en) * | 2005-10-27 | 2016-04-12 | Cook Biotech, Inc. | Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| US20070100351A1 (en) * | 2005-10-31 | 2007-05-03 | Deffenbaugh Daren L | Multiple suture anchor delivery device, suture anchor delivery kit and associated method |
| US20070100350A1 (en) * | 2005-10-31 | 2007-05-03 | Deffenbaugh Daren L | Suture anchor cartridge holder, suture anchor cartridge and associated method |
| US8343204B2 (en) * | 2005-10-31 | 2013-01-01 | Cook Medical Technologies Llc | Composite stent graft |
| US20070100352A1 (en) * | 2005-10-31 | 2007-05-03 | Deffenbaugh Daren L | Cartridge suture anchor delivery device, suture anchor delivery device and associated method |
| US20070112360A1 (en) * | 2005-11-15 | 2007-05-17 | Patrick De Deyne | Bioprosthetic device |
| AU2006320507B2 (en) * | 2005-12-02 | 2012-11-01 | Cook Medical Technologies Llc | Devices, systems, and methods for occluding a defect |
| US20070167981A1 (en) | 2005-12-22 | 2007-07-19 | Nmt Medical, Inc. | Catch members for occluder devices |
| US7815923B2 (en) | 2005-12-29 | 2010-10-19 | Cook Biotech Incorporated | Implantable graft material |
| WO2007079081A1 (en) * | 2005-12-29 | 2007-07-12 | Med Institute, Inc. | Endoluminal device including a mechanism for proximal or distal fixation, and sealing and methods of use thereof |
| WO2007081530A2 (en) * | 2006-01-03 | 2007-07-19 | Med Institute, Inc. | Endoluminal medical device for local delivery of cathepsin inhibitors |
| WO2007084278A2 (en) | 2006-01-06 | 2007-07-26 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Extracellular matrix based gastroesophageal junction reinforcement device |
| US9532943B2 (en) | 2010-12-20 | 2017-01-03 | Cormatrix Cardiovascular, Inc. | Drug eluting patch for the treatment of localized tissue disease or defect |
| AU2007210970B2 (en) * | 2006-01-31 | 2013-09-05 | Cook Biotech Incorporated | Fistula grafts and related methods and systems for treating fistulae |
| US8211168B2 (en) * | 2006-02-21 | 2012-07-03 | Cook Biotech Incorporated | Graft material, stent graft and method |
| US7648527B2 (en) | 2006-03-01 | 2010-01-19 | Cook Incorporated | Methods of reducing retrograde flow |
| US8551135B2 (en) * | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
| US8814947B2 (en) * | 2006-03-31 | 2014-08-26 | W.L. Gore & Associates, Inc. | Deformable flap catch mechanism for occluder device |
| US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
| AU2007240703C1 (en) | 2006-04-19 | 2012-06-14 | Cleveland Clinic Foundation | Twin bifurcated stent graft |
| US8808310B2 (en) * | 2006-04-20 | 2014-08-19 | Integrated Vascular Systems, Inc. | Resettable clip applier and reset tools |
| CA2652138C (en) * | 2006-05-16 | 2016-01-19 | Purdue Research Foundation | Three dimensional purified collagen matrices |
| US20070269476A1 (en) * | 2006-05-16 | 2007-11-22 | Voytik-Harbin Sherry L | Engineered extracellular matrices control stem cell behavior |
| AU2007255072A1 (en) | 2006-05-30 | 2007-12-13 | Cook Incorporated | Artificial valve prosthesis |
| US9307995B2 (en) * | 2006-06-15 | 2016-04-12 | Cook Medical Technologies Llc | Methods, systems and devices for the delivery of endoluminal prostheses |
| EP3025653B1 (en) | 2006-06-21 | 2021-06-16 | Cook Biotech Incorporated | Fistula grafts useful for treating gastrointestinal fistulae |
| US8974542B2 (en) | 2006-06-27 | 2015-03-10 | University of Pittsburgh—of the Commonwealth System of Higher Education | Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions |
| US8556930B2 (en) | 2006-06-28 | 2013-10-15 | Abbott Laboratories | Vessel closure device |
| US8535719B2 (en) * | 2006-07-07 | 2013-09-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
| US20080109070A1 (en) * | 2006-08-10 | 2008-05-08 | Wagner William R | Biodegradable elastomeric scaffolds containing microintegrated cells |
| WO2008024920A1 (en) | 2006-08-24 | 2008-02-28 | Wilson-Cook Medical Inc. | Devices and methods for occluding a fistula |
| US8870914B2 (en) * | 2006-09-12 | 2014-10-28 | Cook Medical Technologies Llc | Medical device and a method for sealing a puncture or an opening |
| US20080063627A1 (en) * | 2006-09-12 | 2008-03-13 | Surmodics, Inc. | Tissue graft materials containing biocompatible agent and methods of making and using same |
| US8084055B2 (en) * | 2006-09-21 | 2011-12-27 | Purdue Research Foundation | Collagen preparation and method of isolation |
| WO2008042311A1 (en) * | 2006-09-28 | 2008-04-10 | Nmt Medical. Inc. | Perforated expandable implant recovery sheath |
| US8529958B2 (en) | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
| JP2010507462A (ja) * | 2006-10-23 | 2010-03-11 | クック・バイオテック・インコーポレーテッド | 増強した成分プロファイルを有する加工したecm材料 |
| US20080103505A1 (en) * | 2006-10-26 | 2008-05-01 | Hendrik Raoul Andre Fransen | Containment device for site-specific delivery of a therapeutic material and methods of use |
| US7871440B2 (en) * | 2006-12-11 | 2011-01-18 | Depuy Products, Inc. | Unitary surgical device and method |
| WO2008086469A1 (en) * | 2007-01-10 | 2008-07-17 | Cook Biotech Incorporated | Implantable devices useful for reinforcing a surgically created stoma |
| US8343536B2 (en) | 2007-01-25 | 2013-01-01 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
| JP2010517703A (ja) | 2007-02-09 | 2010-05-27 | タヘリ ラドュカ エルエルシー | 血管移植片およびそれを加工する方法 |
| BRPI0807261B8 (pt) | 2007-02-09 | 2021-06-22 | Taheri Laduca Llc | conjuntos de cateter carregado com stent |
| WO2008101083A2 (en) | 2007-02-15 | 2008-08-21 | Cook Incorporated | Artificial valve prostheses with a free leaflet portion |
| WO2008109407A2 (en) | 2007-03-02 | 2008-09-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Extracellular matrix-derived gels and related methods |
| US8435551B2 (en) * | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
| WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
| WO2008124361A2 (en) * | 2007-04-06 | 2008-10-16 | Cook Biotech Incorporated | Fistula plugs having increased column strength and fistula plug delivery apparatuses and methods |
| US9138562B2 (en) | 2007-04-18 | 2015-09-22 | W.L. Gore & Associates, Inc. | Flexible catheter system |
| EP2148887B1 (en) * | 2007-04-19 | 2014-04-30 | Fibralign Corporation | Oriented collagen-based materials, films and methods of making same |
| NZ580786A (en) * | 2007-04-24 | 2012-05-25 | Univ Western Australia | Tenocyte containing bioscaffolds and treatment using the same |
| US8591930B2 (en) * | 2007-04-27 | 2013-11-26 | Cook Biotech Incorporated | Growth factor modified extracellular matrix material preparation and methods for preparation and use thereof |
| US20220023503A9 (en) | 2007-05-10 | 2022-01-27 | Aziyo Med, Llc | Extracellular Matrix Tissue Prostheses |
| US20080279833A1 (en) | 2007-05-10 | 2008-11-13 | Matheny Robert G | Laminate sheet articles for tissue regeneration |
| US9283302B2 (en) | 2011-12-16 | 2016-03-15 | Cormatrix Cardiovascular, Inc. | Extracellular matrix encasement structures and methods |
| CN105586358B (zh) | 2007-05-29 | 2020-08-25 | 克里斯多佛·B·里德 | 专能细胞群的生产和使用方法 |
| US20090142400A1 (en) * | 2007-05-31 | 2009-06-04 | Hiles Michael C | Analgesic coated medical product |
| US8226681B2 (en) * | 2007-06-25 | 2012-07-24 | Abbott Laboratories | Methods, devices, and apparatus for managing access through tissue |
| US8535349B2 (en) * | 2007-07-02 | 2013-09-17 | Cook Biotech Incorporated | Fistula grafts having a deflectable graft body portion |
| US20090024106A1 (en) * | 2007-07-17 | 2009-01-22 | Morris Edward J | Method and apparatus for maintaining access |
| WO2009020653A1 (en) | 2007-08-08 | 2009-02-12 | Cleveland Clinic Foundation | Branched stent graft system |
| US9113851B2 (en) | 2007-08-23 | 2015-08-25 | Cook Biotech Incorporated | Fistula plugs and apparatuses and methods for fistula plug delivery |
| US20090069843A1 (en) * | 2007-09-10 | 2009-03-12 | Agnew Charles W | Fistula plugs including a hydration resistant component |
| US8029560B2 (en) | 2007-09-12 | 2011-10-04 | Cook Medical Technologies Llc | Enhanced remodelable materials for occluding bodily vessels |
| US20090136553A1 (en) * | 2007-09-25 | 2009-05-28 | Gerlach Jorg C | Triggerably dissolvable hollow fibers for controlled delivery |
| US20100135964A1 (en) * | 2007-09-27 | 2010-06-03 | Alvarado Carlos A | Tissue grafting method |
| US9023342B2 (en) | 2007-09-27 | 2015-05-05 | Carlos A. Alvarado | Tissue grafting method |
| US10500309B2 (en) * | 2007-10-05 | 2019-12-10 | Cook Biotech Incorporated | Absorbable adhesives and their formulation for use in medical applications |
| US20090112238A1 (en) * | 2007-10-26 | 2009-04-30 | Vance Products Inc., D/B/A Cook Urological Inc. | Fistula brush device |
| CA2703732A1 (en) * | 2007-11-07 | 2009-05-14 | Ovalis, Inc. | Systems, devices and methods for achieving transverse orientation in the treatment of septal defects |
| JP5214223B2 (ja) * | 2007-11-15 | 2013-06-19 | 船井電機株式会社 | プロジェクタ |
| US7846199B2 (en) * | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
| US8057532B2 (en) * | 2007-11-28 | 2011-11-15 | Cook Medical Technologies Llc | Implantable frame and valve design |
| CA2708147A1 (en) * | 2007-12-05 | 2009-06-18 | Musculoskeletal Transplant Foundation | Cancellous bone implant for cartilage repair |
| WO2009076441A1 (en) * | 2007-12-10 | 2009-06-18 | Purdue Research Foundation | Collagen-based matrices with stem cells |
| US20090157101A1 (en) | 2007-12-17 | 2009-06-18 | Abbott Laboratories | Tissue closure system and methods of use |
| US8893947B2 (en) * | 2007-12-17 | 2014-11-25 | Abbott Laboratories | Clip applier and methods of use |
| US20090157177A1 (en) * | 2007-12-18 | 2009-06-18 | Matheny Robert G | Sewing Ring for a Prosthetic Tissue Valve |
| US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
| US20090157170A1 (en) * | 2007-12-18 | 2009-06-18 | Matheny Robert G | Trileaflet Semi-Lunar Prosthetic Tissue Valve |
| US7841502B2 (en) * | 2007-12-18 | 2010-11-30 | Abbott Laboratories | Modular clip applier |
| US7815687B2 (en) * | 2007-12-18 | 2010-10-19 | Med Institute, Inc. | Method of promoting cell proliferation and ingrowth by injury to the native tissue |
| US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
| US20090187215A1 (en) * | 2007-12-19 | 2009-07-23 | Abbott Laboratories | Methods and apparatus to reduce a dimension of an implantable device in a smaller state |
| US8211165B1 (en) | 2008-01-08 | 2012-07-03 | Cook Medical Technologies Llc | Implantable device for placement in a vessel having a variable size |
| US9283266B2 (en) * | 2008-02-28 | 2016-03-15 | University Of Notre Dame | Metastasis inhibition preparations and methods |
| US8956378B2 (en) * | 2008-02-29 | 2015-02-17 | Cook Biotech Incorporated | Coated embolization device |
| US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
| US20100008965A1 (en) * | 2008-04-01 | 2010-01-14 | Pavalko Fredrick M | Biocompatible medical products having enhanced anti-thrombogenic properties |
| WO2009128076A2 (en) | 2008-04-18 | 2009-10-22 | Collplant Ltd. | Methods of generating and using procollagen |
| US8128686B2 (en) * | 2008-04-18 | 2012-03-06 | Cook Medical Technologies Llc | Branched vessel prosthesis |
| EP2113261B1 (en) * | 2008-04-29 | 2013-11-06 | Proxy Biomedical Limited | A Tissue Repair Implant |
| GB2471632B (en) * | 2008-05-02 | 2012-04-18 | Cook Biotech Inc | Self deploying SIS in needle |
| US20110184439A1 (en) * | 2008-05-09 | 2011-07-28 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Biological Matrix for Cardiac Repair |
| US9282965B2 (en) | 2008-05-16 | 2016-03-15 | Abbott Laboratories | Apparatus and methods for engaging tissue |
| EP2326256A1 (en) * | 2008-05-20 | 2011-06-01 | Ovalis, Inc. | Wire-like and other devices for treating septal defects and systems and methods for delivering the same |
| AU2009251335A1 (en) | 2008-05-29 | 2009-12-03 | Cook Biotech Incorporated | Devices and methods for treating rectovaginal and other fistulae |
| US9295757B2 (en) * | 2008-06-10 | 2016-03-29 | Cook Biotech Incorporated | Quilted implantable graft |
| EP3130360B1 (en) * | 2008-06-10 | 2023-06-28 | Cook Biotech Incorporated | Quilted implantable graft |
| US8118832B1 (en) | 2008-06-16 | 2012-02-21 | Morris Innovative, Inc. | Method and apparatus for sealing access |
| WO2010002799A2 (en) * | 2008-07-01 | 2010-01-07 | Cook Biotech Incorporated | Isolated extracellular matrix material including subserous fascia |
| CN103751842A (zh) | 2008-07-30 | 2014-04-30 | 米辛瑟斯有限公司 | 衍生自前胃胞外基质的组织支架 |
| US8513382B2 (en) * | 2008-08-11 | 2013-08-20 | Fibralign Corporation | Biocomposites and methods of making the same |
| US10086079B2 (en) | 2008-08-11 | 2018-10-02 | Fibralign Corporation | Biocomposites and methods of making the same |
| WO2010028025A1 (en) | 2008-09-02 | 2010-03-11 | Gurtner Geoffrey C | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
| CN101366975B (zh) * | 2008-09-03 | 2011-07-20 | 陕西瑞盛生物科技有限公司 | 脱细胞小肠粘膜下层生物材料的制备方法 |
| US20110190680A1 (en) | 2008-09-29 | 2011-08-04 | Yoram Vodovotz | Self-Regulating Device for Modulating Inflammation |
| HUE033504T2 (en) | 2008-09-30 | 2017-12-28 | Univ California | Compositions comprising a decellularized extracellular matrix extracted from cardiac tissue |
| US8398676B2 (en) * | 2008-10-30 | 2013-03-19 | Abbott Vascular Inc. | Closure device |
| WO2010065843A2 (en) | 2008-12-05 | 2010-06-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Biologic scaffold for prevention of pulmonary fibrosis |
| US8734502B2 (en) | 2008-12-17 | 2014-05-27 | Cook Medical Technologies Llc | Tapered stent and flexible prosthesis |
| US8858594B2 (en) * | 2008-12-22 | 2014-10-14 | Abbott Laboratories | Curved closure device |
| US8323312B2 (en) * | 2008-12-22 | 2012-12-04 | Abbott Laboratories | Closure device |
| WO2010078478A1 (en) | 2008-12-31 | 2010-07-08 | Cook Biotech Incorporated | Tissue adjuvants and medical products including the same |
| US8469779B1 (en) | 2009-01-02 | 2013-06-25 | Lifecell Corporation | Method for debristling animal skin |
| US9173644B2 (en) | 2009-01-09 | 2015-11-03 | Abbott Vascular Inc. | Closure devices, systems, and methods |
| US9089311B2 (en) * | 2009-01-09 | 2015-07-28 | Abbott Vascular Inc. | Vessel closure devices and methods |
| US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
| US20100179589A1 (en) * | 2009-01-09 | 2010-07-15 | Abbott Vascular Inc. | Rapidly eroding anchor |
| US9414820B2 (en) * | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
| US20100185234A1 (en) | 2009-01-16 | 2010-07-22 | Abbott Vascular Inc. | Closure devices, systems, and methods |
| US20100183523A1 (en) | 2009-01-22 | 2010-07-22 | Wagner Richard E | Dental composition and method |
| WO2010088678A2 (en) | 2009-02-02 | 2010-08-05 | Cook Biotech Incorporated | Medical bead products |
| CA2752899A1 (en) * | 2009-02-18 | 2010-08-26 | Cormatrix Cardiovascular, Inc. | Compositions and methods for preventing cardiac arrhythmia |
| WO2010099463A2 (en) | 2009-02-27 | 2010-09-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Joint bioscaffolds |
| EP2410945B1 (en) * | 2009-03-26 | 2012-11-21 | William A. Cook Australia Pty. Ltd. | Stent graft |
| EP2427141B1 (en) | 2009-05-06 | 2022-08-10 | Hansa Medical Products, Inc. | Self-adjusting medical device |
| US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
| US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
| US8652500B2 (en) | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
| US8298586B2 (en) | 2009-07-22 | 2012-10-30 | Acell Inc | Variable density tissue graft composition |
| US20110054492A1 (en) * | 2009-08-26 | 2011-03-03 | Abbott Laboratories | Medical device for repairing a fistula |
| AU2010289856B2 (en) * | 2009-09-02 | 2015-02-12 | Lifecell Corporation | Vascular grafts derived from acellular tissue matrices |
| WO2011031827A2 (en) | 2009-09-09 | 2011-03-17 | Cook Biotech Incorporated | Manufacture of extracellular matrix products using supercritical or near supercritical fluids |
| US8663086B2 (en) | 2009-09-28 | 2014-03-04 | Cook Biotech Incorporated | Medical reinforcement graft |
| WO2011044443A2 (en) | 2009-10-09 | 2011-04-14 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Matricryptic ecm peptides for tissue reconstruction |
| US8846059B2 (en) | 2009-12-08 | 2014-09-30 | University Of Notre Dame | Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer |
| US20110150934A1 (en) * | 2009-12-18 | 2011-06-23 | University Of Notre Dame | Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer |
| US8329219B2 (en) * | 2009-12-22 | 2012-12-11 | Cook Biotech Incorporated | Methods for producing ECM-based biomaterials |
| US9814744B2 (en) | 2009-12-22 | 2017-11-14 | University of Pittsburg—Of the Commonwealth System of Higher Education | Decellularized adipose cell growth scaffold |
| US8303624B2 (en) * | 2010-03-15 | 2012-11-06 | Abbott Cardiovascular Systems, Inc. | Bioabsorbable plug |
| AU2010201676B1 (en) | 2010-04-23 | 2010-07-22 | Cook Medical Technologies Llc | Curve forming stent graft |
| WO2011150328A1 (en) | 2010-05-27 | 2011-12-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Wet-electrospun biodegradable scaffold and uses therefor |
| WO2011156338A2 (en) | 2010-06-07 | 2011-12-15 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for modeling hepatic inflammation |
| WO2012009661A2 (en) | 2010-07-15 | 2012-01-19 | Fibralign Corporation | Conductive biopolymer implant for enhancing tissue repair and regeneration using electromagnetic fields |
| EP2598181B1 (en) | 2010-07-31 | 2021-04-21 | Cook Medical Technologies LLC | Collagenous tissue pocket for an implantable medical device, and manufacturing method therefor |
| US8758399B2 (en) | 2010-08-02 | 2014-06-24 | Abbott Cardiovascular Systems, Inc. | Expandable bioabsorbable plug apparatus and method |
| US8603116B2 (en) | 2010-08-04 | 2013-12-10 | Abbott Cardiovascular Systems, Inc. | Closure device with long tines |
| CA2747610C (en) | 2010-08-13 | 2014-09-16 | Cook Medical Technologies Llc | Precannulated fenestration |
| US9101455B2 (en) | 2010-08-13 | 2015-08-11 | Cook Medical Technologies Llc | Preloaded wire for endoluminal device |
| WO2012024390A2 (en) | 2010-08-17 | 2012-02-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biohybrid composite scaffold |
| ES2751393T3 (es) | 2010-08-24 | 2020-03-31 | Univ California | Composiciones y métodos para la terapia cardíaca |
| US9724308B2 (en) | 2010-09-10 | 2017-08-08 | Fibralign Corporation | Biodegradable multilayer constructs |
| AU2011314156A1 (en) | 2010-09-28 | 2013-05-02 | Cook Biotech Incorporated | Devices and methods for treating fistulae and other bodily openings and passageways |
| GB2497475B (en) | 2010-10-01 | 2017-04-19 | Cook Biotech Inc | Kits for tissue reconstruction |
| EP2525742B1 (en) | 2010-10-29 | 2015-03-18 | Cook Medical Technologies LLC | Medical device delivery system and deployment method |
| US9198787B2 (en) | 2010-12-31 | 2015-12-01 | Cook Medical Technologies Llc | Conformable prosthesis delivery system and method for deployment thereof |
| AU2011200858B1 (en) | 2011-02-28 | 2012-04-05 | Cook Medical Technologies Llc | Stent graft with valve arrangement |
| US9149276B2 (en) | 2011-03-21 | 2015-10-06 | Abbott Cardiovascular Systems, Inc. | Clip and deployment apparatus for tissue closure |
| WO2012142419A1 (en) | 2011-04-14 | 2012-10-18 | Lifecell Corporation | Regenerative materials |
| AU2012262554B2 (en) | 2011-05-27 | 2016-09-15 | Cormatrix Cardiovascular, Inc. | Extracellular matrix material conduits and methods of making and using same |
| CA2835863A1 (en) | 2011-05-27 | 2012-12-06 | Cormatrix Cardiovascular, Inc. | Sterilized, acellular extracellular matrix compositions and methods of making thereof |
| US9427233B2 (en) | 2011-06-06 | 2016-08-30 | Cook Medical Technologies, LLC | Vascular occlusion devices and methods |
| EP2720619B1 (en) | 2011-06-14 | 2016-10-26 | Cook Medical Technologies LLC | Fistula closure devices |
| US10022263B2 (en) | 2011-07-14 | 2018-07-17 | Cook Medical Technologies Llc | Sling-based treatment of obstructive sleep apnea |
| US9089523B2 (en) | 2011-07-28 | 2015-07-28 | Lifecell Corporation | Natural tissue scaffolds as tissue fillers |
| US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
| EP2750614B1 (en) | 2011-09-01 | 2015-04-29 | Cook Medical Technologies LLC | Aneurysm closure clip |
| US8728148B2 (en) | 2011-11-09 | 2014-05-20 | Cook Medical Technologies Llc | Diameter reducing tie arrangement for endoluminal prosthesis |
| US20130138219A1 (en) | 2011-11-28 | 2013-05-30 | Cook Medical Technologies Llc | Biodegradable stents having one or more coverings |
| US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
| JP5902827B2 (ja) | 2011-12-09 | 2016-04-13 | アセル,インコーポレイテッド | 止血装置 |
| WO2013096252A1 (en) | 2011-12-20 | 2013-06-27 | Lifecell Corporation | Flowable tissue products |
| AU2012355463C1 (en) | 2011-12-20 | 2016-09-22 | Lifecell Corporation | Sheet tissue products |
| EP2606851B1 (en) | 2011-12-22 | 2015-11-04 | Cook Medical Technologies LLC | Preloaded wire for endoluminal device |
| DK2806907T3 (en) | 2012-01-24 | 2019-02-18 | Lifecell Corp | EXTENDED TISSUE MATRIX |
| WO2013119630A1 (en) | 2012-02-06 | 2013-08-15 | Cook Medical Technologies Llc | Artificial device deployment apparatus |
| EP2811939B8 (en) | 2012-02-10 | 2017-11-15 | CVDevices, LLC | Products made of biological tissues for stents and methods of manufacturing |
| US9504458B2 (en) | 2012-02-17 | 2016-11-29 | Cook Biotech Incorporated | Methods and systems for treating complex fistulae |
| US9782436B2 (en) | 2012-04-24 | 2017-10-10 | Lifecell Corporation | Flowable tissue matrices |
| US11090338B2 (en) | 2012-07-13 | 2021-08-17 | Lifecell Corporation | Methods for improved treatment of adipose tissue |
| US9308107B2 (en) | 2012-08-27 | 2016-04-12 | Cook Medical Technologies Llc | Endoluminal prosthesis and delivery device |
| CA2885327A1 (en) | 2012-09-26 | 2014-04-03 | Lifecell Corporation | Processed adipose tissue |
| US20140121750A1 (en) | 2012-10-31 | 2014-05-01 | Cook Medical Technologies Llc | Fixation Process For Nesting Stents |
| US9669190B2 (en) * | 2012-11-28 | 2017-06-06 | Cook Medical Technologies Llc | Selectively positionable catheter cuff |
| EP2745813A1 (en) | 2012-12-18 | 2014-06-25 | Cook Medical Technologies LLC | Preloaded wire for endoluminal device |
| US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
| US9861466B2 (en) | 2012-12-31 | 2018-01-09 | Cook Medical Technologies Llc | Endoluminal prosthesis |
| US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
| EP3659633A1 (en) | 2013-02-06 | 2020-06-03 | LifeCell Corporation | Methods for localized modification of tissue products |
| CA2899931C (en) | 2013-02-08 | 2019-01-15 | Acell, Inc. | Methods of manufacturing bioactive gels from extracellular matrix material |
| EP2953580A2 (en) | 2013-02-11 | 2015-12-16 | Cook Medical Technologies LLC | Expandable support frame and medical device |
| JP2016512989A (ja) | 2013-03-01 | 2016-05-12 | コーマトリックス カーディオバスキュラー, インコーポレイテッドCorMatrix Cardiovascular, Inc. | ツーピース人工弁 |
| AU2013379744A1 (en) | 2013-03-01 | 2015-09-17 | Cormatrix Cardiovascular, Inc. | Anchored cardiovascular valve |
| EP2964162B1 (en) | 2013-03-07 | 2018-01-17 | Cook Medical Technologies LLC | Tissue ingrowth intestinal bypass sleeve |
| US9993330B2 (en) | 2013-03-13 | 2018-06-12 | Cook Medical Technologies Llc | Endoluminal prosthesis system |
| AU2014227794B2 (en) | 2013-03-15 | 2018-03-01 | Cook Biotech Incorporated | Drug eluting graft constructs and methods |
| AU2014227561C1 (en) | 2013-03-15 | 2017-12-14 | Cook Biotech Incorporated | ECM implant compositions and methods |
| US9308084B2 (en) | 2013-05-03 | 2016-04-12 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valves and methods for anchoring same to cardiovascular structures |
| US10199950B1 (en) | 2013-07-02 | 2019-02-05 | Vlt, Inc. | Power distribution architecture with series-connected bus converter |
| US9861662B2 (en) | 2013-07-03 | 2018-01-09 | University of Pittsburgh—of the Commonwealth System of Higher Education | Bone-derived extra cellular matrix gel |
| WO2015017749A1 (en) | 2013-08-01 | 2015-02-05 | Mohan P Arun | Tissue adjustment implant |
| US20150080940A1 (en) | 2013-09-13 | 2015-03-19 | Cook Medical Technologies Llc | Anti-tumor macrophage m1 morphology inducer |
| US9878071B2 (en) | 2013-10-16 | 2018-01-30 | Purdue Research Foundation | Collagen compositions and methods of use |
| AU2013254913B1 (en) | 2013-11-04 | 2014-09-25 | Cook Medical Technologies Llc | Stent graft with valve arrangement |
| US9814571B2 (en) | 2014-01-08 | 2017-11-14 | Cook Medical Technologies Llc | ECM strip to plug percutaneous heart valve leaks |
| US10286119B2 (en) | 2014-01-24 | 2019-05-14 | University of Pittsburgh—of the Commonwealth System of Higher Education | Extracellular matrix mesh coating |
| WO2015143310A1 (en) | 2014-03-21 | 2015-09-24 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix |
| US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
| ES3027646T3 (en) | 2014-08-27 | 2025-06-16 | Purdue Research Foundation | Collagen-based therapeutic delivery systems |
| CA2962203C (en) | 2014-09-25 | 2020-04-28 | Acell, Inc. | Porous foams derived from extracellular matrix, porous foam ecm medical devices, and methods of use and making thereof |
| US10959826B2 (en) | 2014-10-16 | 2021-03-30 | Cook Medical Technology LLC | Support structure for scalloped grafts |
| US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
| US10183152B2 (en) | 2014-12-12 | 2019-01-22 | Cook Medical Technologies Llc | Cinching peritoneal dialysis catheter |
| CN107405425B (zh) | 2014-12-22 | 2021-03-16 | 阿罗阿生物外科有限公司 | 层叠组织移植产品 |
| US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
| WO2016138416A1 (en) | 2015-02-27 | 2016-09-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Double component mandrel for electrospun stentless, multi-leaflet valve fabrication |
| WO2016138423A1 (en) | 2015-02-27 | 2016-09-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Retrievable self-expanding non-thrombogenic low-profile percutaneous atrioventricular valve prosthesis |
| US11919941B2 (en) | 2015-04-21 | 2024-03-05 | Purdue Research Foundation | Cell-collagen-silica composites and methods of making and using the same |
| US10736991B2 (en) | 2015-09-18 | 2020-08-11 | University of Pittsburgh—of the Commonwealth System of Higher Education | Non-gelling soluble extracellular matrix with biological activity |
| US10173027B2 (en) | 2015-10-07 | 2019-01-08 | Cook Medical Technologies Llc | Methods, medical devices and kits for modifying the luminal profile of a body vessel |
| US20190046211A1 (en) | 2015-12-02 | 2019-02-14 | Cook Biotech Incorporated | Filamentous graft implants and methods of their manufacture and use |
| EP3386558B1 (en) | 2015-12-10 | 2023-10-04 | Cook Biotech Incorporated | Sterilisation methods for a poly(ester urea) fiber material |
| ES3014543T3 (en) | 2016-03-02 | 2025-04-23 | Univ Pittsburgh Commonwealth Sys Higher Education | Matrix bound nanovesicles and their use |
| CA3017747A1 (en) | 2016-03-14 | 2017-09-21 | Regentys Corporation | Method and composition for treating inflammatory bowel disease |
| WO2017189986A1 (en) | 2016-04-28 | 2017-11-02 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compositions comprising extracellular matrix of primitive animal species and related methods |
| WO2017210109A1 (en) | 2016-06-03 | 2017-12-07 | Lifecell Corporation | Methods for localized modification of tissue products |
| EP3269328A3 (en) | 2016-06-08 | 2018-01-24 | Cook Medical Technologies LLC | Cardiac valve implant |
| WO2018007849A1 (en) | 2016-07-05 | 2018-01-11 | Carlos Alvarado | Serous membrane for ocular surface disorders |
| WO2018013361A1 (en) | 2016-07-11 | 2018-01-18 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valves |
| WO2018017611A1 (en) | 2016-07-18 | 2018-01-25 | Cook Biotech Incorporated | Implantable pouch with segmental lamination structure, and related methods of manufacture and use |
| US20180071526A1 (en) | 2016-09-10 | 2018-03-15 | Cook Biotech Incorporated | Electrostimulative graft products, and related methods of use and manufacture |
| US10500079B2 (en) | 2016-10-27 | 2019-12-10 | Cook Medical Technologies Llc | Preloaded branch wire loop constraint |
| EP3320881B1 (en) | 2016-11-10 | 2019-09-04 | Cook Medical Technologies LLC | Diameter reduction constraint arrangement for a stent graft in combination with a stent graft |
| US11191632B2 (en) | 2016-11-10 | 2021-12-07 | Cook Medical Technologies Llc | Temporary diameter reduction constraint arrangement for a stent graft in combination with a stent graft |
| US11045583B2 (en) | 2016-12-22 | 2021-06-29 | Lifecell Corporation | Devices and methods for tissue cryomilling |
| CN110446500B (zh) | 2017-01-31 | 2024-11-26 | 格尼菲斯公司 | 用于基质制备的方法和组合物 |
| WO2018156856A1 (en) | 2017-02-23 | 2018-08-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Stentless biopolymer heart valve replacement capable of living tissue regeneration |
| CN110352064B (zh) | 2017-03-02 | 2023-11-10 | 联邦高等教育系统匹兹堡大学 | 用于癌症治疗的胞外基质(ecm)水凝胶及其可溶级分 |
| EP4252842B1 (en) | 2017-03-02 | 2025-06-25 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Ecm hydrogel for treating esophageal inflammation |
| US11389569B2 (en) | 2017-04-03 | 2022-07-19 | University of Pittsburgh—of the Commonwealth System of Higher Education | Biodegradable, porous, thermally responsive injectable hydrogel as soft tissue defect filler |
| US11739291B2 (en) | 2017-04-25 | 2023-08-29 | Purdue Research Foundation | 3-dimensional (3D) tissue-engineered muscle for tissue restoration |
| KR102872720B1 (ko) | 2017-05-05 | 2025-10-16 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 기질 결합 소낭의 안구에의 적용 |
| US11357660B2 (en) | 2017-06-29 | 2022-06-14 | Cook Medical Technologies, LLC | Implantable medical devices for tissue repositioning |
| WO2019079195A1 (en) | 2017-10-16 | 2019-04-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | GENETICALLY MODIFIED MESENCHYMAL STEM CELLS FOR USE IN CARDIOVASCULAR PROSTHESES |
| US10821205B2 (en) | 2017-10-18 | 2020-11-03 | Lifecell Corporation | Adipose tissue products and methods of production |
| US11123375B2 (en) | 2017-10-18 | 2021-09-21 | Lifecell Corporation | Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products |
| WO2019079672A1 (en) | 2017-10-19 | 2019-04-25 | Lifecell Corporation | ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION |
| US11246994B2 (en) | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
| WO2019094734A1 (en) | 2017-11-09 | 2019-05-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Decellularization and functionalization of extracellular matrix biomaterials |
| US11291570B2 (en) | 2018-04-27 | 2022-04-05 | Cook Medical Technologies Llc | Hybrid stent and delivery system |
| US12440444B2 (en) | 2018-05-03 | 2025-10-14 | University of Pittsburgh—of the Commonwealth System of Higher Education | Matrix bound vesicles (MBVS) containing IL-33 and their use |
| JP2021527518A (ja) | 2018-06-21 | 2021-10-14 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 食道粘膜下流体クッションとしての膀胱ecmヒドロゲルの使用 |
| CA3103093A1 (en) | 2018-06-21 | 2019-12-26 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Extracellular matrix (ecm) hydrogel as a submucosal fluid cushion |
| JP2021529024A (ja) | 2018-06-21 | 2021-10-28 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 食道粘膜下流体クッションとしての細胞外マトリックス(ecm)ヒドロゲルの使用 |
| AU2018214103B1 (en) | 2018-08-09 | 2018-10-04 | Cook Medical Technologies Llc | A stent-graft |
| CN113226387B (zh) | 2018-11-19 | 2024-02-23 | 美国政府(由卫生和人类服务部的部长所代表) | 可生物降解的组织置换植入物及其用途 |
| WO2020186082A1 (en) | 2019-03-13 | 2020-09-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Acoustic extracellular matrix hydrogels and their use |
| AU2020283895A1 (en) | 2019-05-30 | 2022-01-06 | Lifecell Corporation | Biologic breast implant |
| EP4096635A4 (en) | 2020-01-27 | 2024-02-21 | GeniPhys, Inc. | BIOLOGICAL FILLER FOR TISSUE RESTORATION AND REGENERATION |
| AU2021225836A1 (en) | 2020-02-28 | 2022-09-15 | Elutia Inc. | Placental tissue compositions and methods |
| BR112022018377A2 (pt) | 2020-03-16 | 2022-11-08 | Biosearch S A | Biocompósitos compreendendo probióticos, colágeno e polissacarídeo extracelular bacteriano e usos dos mesmos |
| CN116322529A (zh) | 2020-07-27 | 2023-06-23 | 库克生物技术股份有限公司 | 用于供应手术钉排加强件的系统和方法 |
| US11992577B2 (en) | 2020-07-27 | 2024-05-28 | Cook Biotech Incorporated | Adhesive for surgical staple line reinforcement |
| US12514958B2 (en) | 2020-08-17 | 2026-01-06 | Elutia Med Llc | Depots and encasement structures for implantable devices |
| US20230364301A1 (en) | 2020-09-11 | 2023-11-16 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for preparation of a terminally sterilized hydrogel or colloidal suspension derived from extracellular matrix, and uses thereof |
| US11826490B1 (en) | 2020-12-29 | 2023-11-28 | Acell, Inc. | Extracellular matrix sheet devices with improved mechanical properties and method of making |
| EP4294327A4 (en) | 2021-02-18 | 2024-11-13 | Cormatrix Cardiovascular, Inc. | REINFORCED VALVE PROSTHESES |
| EP4294328A4 (en) | 2021-02-22 | 2024-11-20 | Cormatrix Cardiovascular, Inc. | ADAPTABLE FABRIC PROSTHETIC VALVES |
| WO2022251499A1 (en) | 2021-05-28 | 2022-12-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods to generate macular, central and peripheral retinal pigment epithelial cells |
| CA3220433A1 (en) | 2021-05-28 | 2022-12-01 | Arvydas Maminishkis | Biodegradable tissue scaffold with secondary matrix to host weakly adherent cells |
| US20250345478A1 (en) | 2022-05-05 | 2025-11-13 | Cook Biotech Incoporated | Photocrosslinkable synthetic polymers |
| CA3251939A1 (en) | 2022-05-05 | 2023-11-09 | Cook Biotech Incorporated | SUBTISSUE IMPLANT MATERIAL |
| WO2024229363A1 (en) | 2023-05-03 | 2024-11-07 | Cook Biotech Incorporated | Coated medical products, and methods for preparing and using same |
| WO2025048835A1 (en) | 2023-09-01 | 2025-03-06 | Bhavin Shah | Polycaprolactone-based fibers and implants including same |
| WO2025111529A2 (en) | 2023-11-22 | 2025-05-30 | Cook Biotech Incorporated | Drug depot-bearing medical graft implants, and related methods and components |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT261800B (de) * | 1966-08-22 | 1968-05-10 | Braun Internat Gmbh B | Verfahren zur Herstellung von röhrenförmigen, glatten bzw. mit einem Gewinde versehenen Gewebe-Blutgefäß-Prothesen |
| US4502159A (en) * | 1982-08-12 | 1985-03-05 | Shiley Incorporated | Tubular prostheses prepared from pericardial tissue |
-
1988
- 1988-07-11 US US07/217,299 patent/US4902508A/en not_active Expired - Lifetime
-
1989
- 1989-06-15 ZA ZA894551A patent/ZA894551B/xx unknown
- 1989-06-15 IL IL9062289A patent/IL90622A/en unknown
- 1989-06-23 CH CH902/90A patent/CH681506A5/de not_active IP Right Cessation
- 1989-06-23 JP JP1508210A patent/JP2539934B2/ja not_active Expired - Lifetime
- 1989-06-23 BR BR898907538A patent/BR8907538A/pt not_active IP Right Cessation
- 1989-06-23 KR KR1019900700514A patent/KR0131821B1/ko not_active Expired - Lifetime
- 1989-06-23 FI FI910113A patent/FI910113A0/fi unknown
- 1989-06-23 WO PCT/US1989/002776 patent/WO1990000395A1/en not_active Ceased
- 1989-06-23 HU HU894789A patent/HU207448B/hu not_active IP Right Cessation
- 1989-06-23 CH CH3792/91A patent/CH681856A5/de not_active IP Right Cessation
- 1989-06-23 AT AT89908901T patent/ATE112963T1/de not_active IP Right Cessation
- 1989-06-23 DE DE68918943T patent/DE68918943T2/de not_active Expired - Lifetime
- 1989-06-23 EP EP89908901A patent/EP0424463B1/en not_active Expired - Lifetime
- 1989-06-27 AU AU37091/89A patent/AU613499B2/en not_active Expired
- 1989-06-30 PH PH38883A patent/PH26921A/en unknown
- 1989-07-03 NZ NZ229797A patent/NZ229797A/xx unknown
- 1989-07-06 MX MX016707A patent/MX171671B/es unknown
- 1989-07-07 CA CA000605031A patent/CA1335432C/en not_active Expired - Lifetime
- 1989-07-07 PT PT91096A patent/PT91096B/pt not_active IP Right Cessation
- 1989-07-10 ES ES8902418A patent/ES2019146A6/es not_active Expired - Lifetime
- 1989-07-10 DK DK198903405A patent/DK175719B2/da not_active IP Right Cessation
- 1989-07-10 CN CN89104864A patent/CN1018893B/zh not_active Expired
- 1989-07-11 IE IE222289A patent/IE67279B1/en not_active IP Right Cessation
- 1989-07-11 AR AR89314366A patent/AR244539A1/es active
-
1990
- 1990-12-21 OA OA59928A patent/OA09633A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT91096B (pt) | Composicao de enxerto de tecido | |
| US4956178A (en) | Tissue graft composition | |
| AU2001255741B2 (en) | Decellularized vascular prostheses | |
| Dobrin et al. | Mechanical and histologic changes in canine vein grafts | |
| JP4131611B2 (ja) | 治療用供給システムを備えた小孔生物的移植片 | |
| JP2002516703A (ja) | 生物工学により作成した血管移植片支持体補綴 | |
| Rumisek et al. | Heat-denatured albumin-coated Dacron vascular grafts: physical characteristics and in vivo performance | |
| Ohki et al. | Anastomotic intimal hyperplasia: a comparison between conventional and endovascular stent graft techniques | |
| RU2037317C1 (ru) | Тканевый трансплантат | |
| Biasi et al. | Processed bovine pericardium as patch angioplasty for carotid endarterectomy: a preliminary report | |
| Yoffe et al. | Experimental study of a novel suture-less aortic anastomotic device | |
| Noishiki et al. | Development and evaluation of a pliable biological valved conduit. Part I: preparation, biochemical properties, and histological findings | |
| Niles et al. | Pathology of Heart Valve Replacement Surgery:: Autopsies of 62 Patients with Starr-Ed wards Prostheses | |
| Itoh et al. | Vascular endoscopy for major vascular reconstruction: experimental and clinical studies | |
| RU2142751C1 (ru) | Способ реваскуляризации кисти | |
| Huber et al. | Rupture of a polypropylene suture after aortic operation: a scanning electronic microscopical assessment of potential mechanisms | |
| Hübner et al. | Autologous everted vein graft for repairing long-section urethral defects | |
| Zeeman et al. | The significance of resection length on the patency rate, and the histopathology, of experimentally avulsed and microsurgically repaired blood vessels | |
| RU2818619C2 (ru) | Способ пластической реконструкции дефекта почечной вены фрагментом серповидной связки печени | |
| RU2775196C1 (ru) | Способ хирургического лечения компрессии левого главного бронха сосудистыми структурами | |
| SU1648391A1 (ru) | Способ хирургического лечени облитерирующего эндартериита в стадии деструкции | |
| Sarioğlu et al. | Early and moderate long-term results of a new surgical technique for repair of aortic coarctation | |
| Abdullah et al. | Superior Vena Cava Obstruction Bypass--An Alternative Technique Using Bovine Pericardial Conduit: A Case Report | |
| Furdella | Acute Preclinical Evaluation of Compliance-Matched and TGFβ2 Eluting Vascular Grafts | |
| Stanger | A brief history of aortic pathology and surgery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19940617 |
|
| MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20090707 |